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Abstract
Increased systemic infections and growing resistance of Candida species in
immunosuppressed people have prompted research for additional treatment options. The
purpose of this quantitative study was to investigate the potential of lemongrass, oregano,
and thyme essential oils tested individually, combined, and combined with the antifungal
agents fluconazole and caspofungin to kill Candida albicans isolates in a controlled
laboratory setting. This study was grounded on the theoretical concepts of the
epidemiologic triangle model. The experimental data collected were used to investigate
risk factors related to age, gender, race, and comorbidities. Kill rates of lemongrass,
oregano, and thyme essential oils individually and combined, kill rates of fluconazole,
caspofungin, and the kill rates when the antifungals were each combined with the 3
essential oils were compared using 117 isolates recovered from bloodstream infections
between January 2009 through August 1, 2017. The data collected were analyzed using
2-way repeated ANOVAS. According to study results, there were statistically significant
increases in kill rates when the isolates were exposed to any of the combinations of
essential oils tested. Using binomial and multinomial regression to analyze age, gender,
race, and comorbidities resulted in the age group 25-34, kidney failure, and solid organ
tumor cancer all being statistically significantly associated with an increased risk for
Candida albicans bloodstream infections, and multiple organ failure negatively
associated with the risk. Health care practitioners can use the results of this study to
reduce the number of patients becoming infected with life-threatening yeast infections,
which could reduce the costs associated with infections.
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Chapter 1: Introduction to the Study
Introduction
Candida infections are considered the second most numerous cause of fungal
infections worldwide (Brown et al., 2012). Although most infections are superficial,
invasive fungal infections, including those caused by Candida, are responsible for over
an estimated 1.5 million infections annually worldwide (Brown et al., 2012). An accurate
measurement of the burden of fungal disease is likely underestimated due to misdiagnosis
and the lack of required reporting in the United States for all invasive fungal disease
except for Coccidiodes, which causes Valley Fever (Brown et al., 2012). The Centers for
Disease Control and Prevention (CDC, n.d.2) collects data on invasive candidiasis
through the Emerging Infections Programs (EIP) from 10 state health departments; these
states’ local health departments; academic institutions; as well as other federal agencies,
public health and clinical laboratories, and health care facilities. Increased numbers of
successful organ transplants, as well as improvements in medical treatments for
HIV/AIDS and cancers, have created an increasing number of patients who are
immunosuppressed for extended lengths of time (Pellegrino, Onder, & Schmidt, n.d.).
This rise in at-risk populations has caused an increase in organisms that are considered
pathogenic, as well as the development of Candida isolates that are resistant to the
limited available treatment options (Cleveland et al., 2012). Additional difficulties occur
with being able to detect and treat these infections quickly as initial symptoms may be
nonspecific for invasive Candida infections (Brown et al., 2012).
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Background
Through the CDC’s EIP program, data are also collected through active,
population-based surveillance for candidemia in seven of the current EIP sites: Georgia,
Maryland, Minnesota, New Mexico, New York, Oregon, and Tennessee (CDC, 2017).
However, epidemiology studies on overall incidence of invasive Candida have been
difficult to determine due to a lack of required reporting in other areas and the potential
for misdiagnosis (Brown et al., 2012). Some scholars have evaluated the status of
antifungal resistance epidemiology in haematological malignant patients (Alcazar-Fuoli
& Mellado, 2014). Researchers have reported on the mechanisms of the virulence factors
of Candida species and the ability to cause severe infections (Bliss et al., 2012). This
knowledge added to the need to analyze the potential for Candida species to possess
adaptive resistance mechanisms, the prevalence of these resistant organisms in certain
patient populations, and the discrepancy that exists between in-vitro and in-vivo results
due to how the host responds differently between colonizing Candida and invasive
Candida (Lewis, Viale, & Kontoyiannis, 2012).
Studies on various essential oils and the effect on survival of yeast and bacteria
have brought additional areas for further investigation. Groundwork for treating Candida
with essential oils in-vivo and the chemical compounds that cause disruption or death to
yeast cells have also been studied using essential oils extracted from oregano plants
(Cleff et al., 2010). The inhibition of Candida albicans and Aspergillus fumagatus with
thyme essential oil has also been studied. Thyme sterilized culture growth of both
organisms (Bellete et al., 2012). Sajjad Ahmad Khan, Malik, and Ahmad (2012) used 21
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essential oils against two quality control strains of Candida albicans alone and in
conjunction with fluconazole and amphotericin B. All of these essential oils had various
degrees of efficacy against strains, including the resistance strain. Sajjad Ahmad Khan et
al. (2012), however, did not test any essential oils against patient recovered isolates. Rath
and Mohapatra (2015) studied the effect of black cumin, curry leaf, Ajwain, and Betel
leaf against Candida albicans, Candida tropicalis, Candida glabrata, and Candida
parapsilosis. Rath and Mohapatra found that essential oils showed efficacy against the
various strains of Candida, even after the oils were autoclaved. Although Rath and
Mohapatra had multiple species of Candida, the essential oils that were tested would not
be readily available in the United States. Rath and Mohapatra, however, tested the
efficacy of essential oils after exposure to intense heat (from an autoclave). Different
mechanisms of delivery of essential oils to Candida isolates were evaluated by testing the
minimum inhibitory concentration in vapor and gas phase for various essential oils, and it
was determined that Cymbopogon citratus (lemongrass) was highly effective in the vapor
phase against Candida due to the ability for the essential oils to change surface structures
on the yeast cell walls in a short time (Tyagi & Malik, 2010). The potential to diffuse
essential oils into the air may provide a treatment option not only for a patient but also for
the environment and, thus, disrupt the ability of the yeast to maintain contact with the
patient through the host environment.
Age, gender, and an immunocompromised state have been shown to be associated
with the risk of blood stream infections (Kaye et al., 2011; Yang et al., 2014). Scholars
have not examined race as a risk factor or examined age and gender specifically to
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Candida albicans blood stream infections. The opportunity to examine data and
investigate Candida albicans isolated from blood stream infections from a large teaching
hospital with patients who are immunocompromised for various reasons provided an area
of study that has not been previously published and could add significantly to the body of
knowledge. This study could provide a foundation for further research involving patients
to improve outcomes and empower individuals in treatment options.
Problem Statement
Improvements in medical treatments for cancer, HIV/AIDS, as well as a rise in
successful organ transplants have created an increased number of long-term
immunosuppressed people (Pellegrino et al., n.d.). This immunosuppression has caused
an increase in life-threatening fungal and yeast infections (CDC, 2011). There is a
growing problem with ineffective treatment methods for life-threatening yeast infections
in immunocompromised patients. Treatment options for Candida infections have
become limited due to resistance of the organism to multiple antifungal medications
(Brown et al., 2012). This problem has caused not only an increased cost for treatment,
but also an elevated risk of mortality for patients infected with Candida (Zaoutis et al.,
2005). Fewer traditional treatment options, along with increased mortality rates in both
children and adults with Candida infections, necessitates different methods and new
tactics to treat these life-threatening infections (Zaoutis et al., 2005).
Traditional treatments for Candida infections include antifungal medications,
such as fluconazole and amphotericin B (CDC MASTER, n.d.). These drugs, however,
are known to be toxic to the body, and resistance to these medications has continued to
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rise (CDC, 2011). There are limited treatment options against Candida infections when
the organism has become resistant to multiple medications (Brown et al., 2012). This
problem has increased the risk of mortality in infected patients (Zaoutis et al., 2005).
Essential oils may provide a synergistic treatment to improve antifungal medication
activity against Candida albicans (Sajjad Ahmad Khan et al., 2012). In investigations of
mechanisms that create antifungal activity in the chemical compounds found in essential
oils naturally derived from plants, Khan et al. (2011) suggested that these compounds can
cause lesions in the membrane of the yeast cell wall, alter the permeability of the plasma
membrane, or cause oxidative stress to the organism. Despite results from scholars who
indicated promising in-vitro results from the efficacy of essential oil treatment against
Candida and its virulence properties, there are limited treatment options used for
multidrug resistant Candida infections (Tyagi & Malik, 2010).
Purpose of the Study
The purpose of this study was to develop a system to examine the potential of
three essential oils (lemongrass, oregano, and thyme) tested individually, combined, and
then combined in conjunction with antifungal medications to kill Candida albicans
isolates in a controlled laboratory setting. An experimental, quantitative method was
used to evaluate the impact that the use of these oils, in combination with antifungal
medications, had on the ability to minimize or prevent virulence factors, as well as the
potential to kill Candida albicans isolates in laboratory in-vitro testing. Candida
albicans isolates were collected from previously saved organisms that were recovered
from blood cultures of patients hospitalized in a large teaching hospital. Information on
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age, gender, race, and comorbidities were also collected from the isolates to investigate
any significance related to Candida albicans infections and these covariates. In this
study, I wished to develop a framework to examine the in-vitro effectiveness of three
separate essential oils used separately and together in the presence of any antifungal
medications an immunocompromised patient may be prescribed.
Research Questions and Hypotheses
1.

RQ1: How does the use of lemongrass essential oil compare to standard
antifungal medications for Candida albicans kill rates in laboratory testing?
H01: There is no significant difference in kill rates for the use of
lemongrass essential oil compared to standard antifungal medications for Candida
albicans in laboratory testing.
Ha1: There is a significant difference in kill rates for the use of lemongrass
essential oil compared to standard antifungal medications for Candida albicans in
laboratory testing.

2.

RQ2: How does the use of oregano essential oil compare to standard antifungal
medications for Candida albicans kill rates in laboratory testing?
H02: There is no significant difference in kill rates for the use of oregano
essential oil compared to standard antifungal medications for Candida albicans in
laboratory testing.
Ha2: There is a significant difference in kill rates for the use of oregano
essential oil compared to standard antifungal medications for Candida albicans in
laboratory testing.
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3.

RQ3: How does the use of thyme essential oil compare to standard antifungal
medications for Candida albicans kill rates in laboratory testing?
H03: There is no significant difference in kill rates for the use of thyme
essential oil compared to standard antifungal medications for Candida albicans in
laboratory testing.
Ha3: There is a significant difference in kill rates for the use of thyme
essential oil compared to standard antifungal medications for Candida albicans in
laboratory testing.

4.

RQ4: How does the combined use of lemongrass, oregano, and thyme essential
oils compare to standard antifungal medications for Candida albicans kill rates in
laboratory testing?
H04: There is no significant difference in kill rates for the combined use of
lemongrass, oregano, and thyme essential oils compared to standard antifungal
medications for Candida albicans in laboratory testing.
Ha4: There is a significant difference in kill rates for the combined use of
lemongrass, oregano, and thyme essential oils compared to standard antifungal
medications for Candida albicans in laboratory testing.

5.

RQ5: How does the combined use of lemongrass, oregano, and thyme essential
oils when used with standard antifungal treatments compare to standard antifungal
medications for Candida albicans kill rates in laboratory testing?
H05: There is no significant difference in kill rates for the combined use of
lemongrass, oregano, and thyme essential oils when used with standard antifungal
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medications compared to standard antifungal medications for Candida albicans in
laboratory testing.
Ha5: There is a significant difference in kill rates for the combined use of
lemongrass, oregano, and thyme essential oils when used with standard antifungal
medications compared to standard antifungal medications for Candida albicans in
laboratory testing.
6.

RQ6: How does the combined use of lemongrass, oregano, and thyme essential
oils compare to standard antifungal medications for disruption of the virulence
factor of germ tube production of Candida albicans in laboratory testing?
H06: There is no significant difference in the combined use of lemongrass,
oregano, and thyme essential oils compared to standard antifungal medications for
disruption of the virulence factor of germ tube production of Candida albicans in
laboratory testing.
Ha6: There is a significant difference in the combined use of lemongrass,
oregano, and thyme essential oils compared to standard antifungal medications for
disruption of the virulence factor of germ tube production of Candida albicans in
laboratory testing.

7.

RQ7: How do the covariates age, gender, race, or comorbidities contribute to the
risk of Candida albicans bloodstream infections?
H07: Age, gender, race, or comorbidities do not significantly contribute to
an increased risk of Candida albicans bloodstream infections.
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Ha7: Age, gender, race, or comorbidities do significantly contribute to an
increased risk of Candida albicans blood stream infections.
Theoretical Framework
The epidemiological triangle was used as the framework for the research. The
epidemiological triangle provides a model that is based on the premise that disease does
not occur randomly throughout a population; instead, certain members of this population
may have a higher risk for a disease that does not randomly occur throughout the rest of
the population (Soumpasis, Knapp, & Pitt, 2015). The triangle can also be used to help to
identify increased risk factors for development of disease in these subpopulations (CDC,
2016). This model of causation is composed of a susceptible host, an external agent, and
the environment in which the host and the agent are in contact with each other (Orr,
2005). Contact brings about the disease as the environment provides the means of
transmission of the infectious agent into the susceptible host (CDC, 2016). In order to
develop public health control measures of infectious diseases, all three components and
how they interact need to be assessed (CDC, n.d.). Using the epidemiologic triangle as a
framework for the research provided a foundation of an immunocompromised host,
which can be placed into the susceptible host vertex, Candida albicans, which is placed
at the agent vertex, and the environment which is at the final vertex of the triangle. In
this study, I evaluated potential means to disrupt this interaction from causing disease by
breaking one of the sides of the triangle. In addition, the relationship of these three
components that enables disease to occur was also used for interpretation of the results
from the study. For example, the potential to prevent virulence factors from forming
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would disrupt the interaction of the agent to enter and cause disease in the host. Other
areas of disruption could involve prevention of the agent from replicating and surviving
in either the host or the environment. Although I focused on prevention of virulence
factor development, as well as yeast cell inhibition and death, this framework also has
future implications for disruption of the yeast in the environment (see Figures 1 and 2).

Figure 1. Epidemiological triangle.
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Figure 2. Disruption of epidemiological triangle.

Nature of the Study
The nature of this study was quantitative. An experimental study design was used
to evaluate any impact that the use of lemongrass, oregano, and thyme essential oils
individually had on Candida albicans kill rates in the laboratory, followed by the
combined use of these essential oils compared to standard antifungal medications kill
rates of Candida albicans in laboratory testing. Next, the combined use of lemongrass,
oregano, and thyme essential oils, along with standard antifungal treatments, were
compared to standard antifungal medications for Candida albicans kill rates in laboratory
testing. Finally, the combined use of lemongrass, oregano, and thyme essential oils were
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compared to standard antifungal medications for the ability to cause disruption of germ
tube production of Candida albicans in laboratory testing. This design method provided
a way to assure a high degree of validity with the ability to culture each Candida isolate
before and after testing, as well as enabling the research to be duplicated (FrankfortNachmias & Nachmias, 2007).
Definitions
Chirality: Pertains to a molecule’s characteristic mirror image, which was used to
assess that the essential oil tested does not contain synthetic constituents (doTERRA
CPTG Certified Pure Therapeutic Grade Quality Testing, 2016).
Cytotoxic effects: Causes harm to cells primarily through cell wall disruption,
which can decrease the cell’s functions or cause cell death (Ramage et al., 2012).
Comorbidities: Preexisting conditions or chronic diseases that are listed upon
admission to the hospital.
Fournier transfer infrared spectroscopy: Used to identify structural components
of compounds found in essential oils. This was used to determine the quality of the
sample based upon previously recognized high-quality standards (doTERRA CPTG
Certified Pure Therapeutic Grade Quality Testing, 2016).
Fungicidal: A compound that kills fungus including yeast (Bachmann et al.,
2002).
Fungistatic: A compound that inhibits fungus but does not kill it. When the
compound is removed, the fungus can resume growth activities (Bachmann et al., 2002).
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Germ tube: A pseudo-hyphal extension that is used by Candida albicans to invade
the host mucosal membrane (Bliss et al., 2012).
Haematological malignant patients: Patients with cancer involving the blood and
lymphatic system (Alcazar-Fuoli & Mellado, 2014).
Invasive fungal disease: A fungal infection that has spread to one or more systems
or organs in the host (Enoch, Ludlam, & Brown, 2006).
Minimum inhibitory concentration: The lowest concentration of an antimicrobial
that will inhibit visible growth (Clinical and Laboratory Standards Institute [CLSI],
2015).
Nitric oxide: A free radical found in the body that is used for multiple cellular
processes (Leyva-Lopez, Nair, Bank, Cisneros-Zevallos, & Heredia, 2016).
Prophylaxis: An antifungal medication taken to prevent an infection (Sanguinetti,
Posteraro, & Lass-Florl, 2015).
Reactive oxygen species: A byproduct from cellular oxygen metabolism that can
cause severe cellular damage in high amounts (Leyva-Lopez et al., 2016).
Tissue conditioner: A temporary lining that is placed between dentures and the
gum to promote healing of the gum tissue (Amornvit, Choonharuangdej, & Srithavaj,
2014).
Assumptions
Essential oil components are effective against Candida albicans isolates (Bellete
et al., 2012; Khan et al., 2011; Sajjad Ahmad Khan et al., 2012). Essential oil
components effective against yeast isolates consistently produce similar results on
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Candida albicans strains isolated from patients as well as established Candida albicans
quality control strains (Bellete et al., 2012; Kalemba & Kunicka, 2003; Khan et al., 2011;
Korenblum et al., 2013; Rath & Mohapatra, 2015; Shah et al., 2011). In this study I
assumed that the samples taken from a large teaching hospital also provided a variety of
patient demographics due to the diversity of adult patient population seen at the hospital.
The methods used to evaluate sensitivity of Candida albicans isolates to the essential oils
and antifungals were assumed to be accurate based upon established scientific methods
used to determine antimicrobial susceptibility ranges for various organisms including
Candida albicans (CLSI, 2015). Time to kill rates were also assumed to be accurate
based upon previously established laboratory standards and would be reproducible upon
repeat testing (Woolfrey, Lally, & Tait, 1986).
Scope and Delimitations
I used patient demographics and isolates recovered from the patient population of
a large teaching hospital. The purpose of this research was to not only evaluate the effect
of lemongrass, oregano, and thyme essential oils against Candida albicans but to also
investigate any potential risk factors of people who acquire Candida albicans
bloodstream infections during their patient stay at the hospital. Other variables and
conditions that could further impact risk for Candida albicans bloodstream infections,
such as potential ubiquitous nature of Candida albicans in this hospital as opposed to
other hospital locations and risk factors based upon population ethnicities that are not
generally seen in this geographic location, were outside the scope of this research. The
impact of long-term prophylaxis of antifungal medications on risk factors was not
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assessed. Isolates and patient information spanned 7 years in order to obtain an adequate
sample, and there was potential that the risk factors as well as the characteristics of the
Candida albicans isolates may vary over this time period and may, therefore, not provide
accurate information of current risk factors.
Limitations
Limitations for this study included potential changes in treatment protocols for the
time-period examined, the ability to grow the organisms that have been previously
frozen, and using a local patient population and not a nationwide population. Collecting
data from a large teaching hospital’s patient population may also limit the validity of
overall effectiveness of essential oil treatment in other patient populations. Other
limitations included not being able to use actual patients’ interactions with essential oils
in conjunction with the antifungal treatments. Only using Candida albicans strains
isolated from blood stream infections instead of isolates from less life-threatening
Candida albicans infections and not investigating other emerging yeast pathogens were
also known limitations for this study.
Significance of the Study
To address these gaps in knowledge, I evaluated a large number of clinically
isolated Candida albicans with various susceptibility patterns. The impact that the
essential oils have on Candida isolates was assessed to determine whether essential oil
treatments could be used to improve outcomes of patients infected with Candida. This
research is important for people who are immunocompromised and living with chronic
infections of Candida that can turn life-threatening or for those who have been on long-

16
term prophylactic treatment with antifungal medications who are at risk of developing
infections with multidrug resistant Candida species (Wanke, Dos Santos Lazera, &
Nucci, 2000). The findings from this research could provide positive social change by
reducing the number of patients becoming infected with life-threatening yeast infections,
which not only would reduce mortality but would also reduce the costs associated with
serious infections. There is the possibility for the results of this research to provide
alternative options for treatment, to provide methods for improving treatment, and for
future research to enable patients to feel empowered in treatment options. This study also
has potential to become a foundation for other studies including in-vivo treatment with
immunocompromised adults as well as within other populations including pediatrics,
where treatment options due to patient age are even more limited (Bliss et al., 2012).
Summary and Transition
This research dissertation has five sections. In Chapter 1, I presented an overview
of the problem and why the research was performed. Current limited treatment options
have provided opportunities to seek additional methods to improve treatment capabilities.
Few studies have been done using widely available essential oils and commonly used
antifungal medications with a large number of clinically significant isolates of Candida
albicans. This study provided an opportunity to examine experimental attributes as well
as investigating covariates as risk factors for Candida albicans infections.
Chapter 2 provides an in-depth literature review on attributes of Candida
albicans, alternative treatments, and covariates associated with risk of infection. This
chapter includes an overview; theoretical framework; risk factors associated with blood
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stream infections; immunocompromised patients and prophylaxis; virulence and
resistance mechanisms of Candida albicans; alternative treatment options; host defense
mechanisms; essential oil treatment testing; chemical mechanisms of actions for
lemongrass, oregano, and thyme; combining use of essential oils and antimicrobials; host
cell toxicity to essential oils; and methodology. In Chapter 3, I describe the design of the
study, methodologies used, the study population, testing procedures, and variables tested.
In Chapter 4, I discuss the results of the research that was performed including data
collection, treatment methods, analyses of statistical test, and a summary of these results.
In Chapter 5, I finish with the conclusion of these results, limitations of the study,
recommendations, and implications for social change.
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Chapter 2: Literature Review
Introduction
The CDC (2013) reported that Candida species is the fourth leading cause of
health-care-associated bloodstream infections. Hospital life-threatening yeast infections
in immunocompromised patients have become more difficult to treat due to resistance to
multiple antifungal medications (Brown et al., 2012). This growing problem of finding
effective treatment options has not only caused the cost for treatment to rise but has also
contributed to rising mortality rates in both adults and children. Traditional treatment for
Candida infections include fluconazole and amphotericin B (CDC MASTER,n.d.);
however, although these drugs are known to be toxic to the body, limited available
antifungal medications have left few other options (CDC, 2011).
Researchers have proposed that chemical compounds found in essential oils
naturally derived from plants can inhibit yeast and fungus and may also provide a
synergistic treatment to improve antifungal medication activity against Candida albicans
in-vitro (Sajjad Ahmad Khan et al., 2012). Although there has been promising in-vitro
results indicating efficacy of essential oil treatment options for multidrug resistant
Candida infections, there are limited options used for treatment of these dangerous
infections (Tyagi & Malik, 2010).
In this chapter, I review the literature related to Candida virulence factors, the
disruption of virulence properties using antifungal medications, drug resistance
mechanisms of Candida albicans, and outcomes for Candida species when exposed to
various essential oils. This review was used to create a foundation for discerning areas of
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viable treatment options for Candida albicans infections based upon published, evidencebased, scientific research, as well as any risk factors of Candida bloodstream infections
that have been shown to be related to age, gender, race, and comorbidities.
Literature Search Strategy
Articles were chosen using the CINAHL and MEDLINE simultaneous database
search. Inclusion parameters included peer-reviewed articles from 2000 to the present,
full-text available, and written in English. Exclusions included abstract only, articles not
peer reviewed, articles in another language, and articles that had limited number of
samples or patients tested (fewer than five). Although the initial intent was to limit the
research articles to the past 5 years, some of the primary investigations and research were
published prior to 2011. Initial keywords used were Candida and essential oils. This
search brought results for 489 articles. There were many articles from research
performed outside of the United States and with oils other than the three used for this
research project. A review of the first 10 articles provided four articles for review.
Another search with the keywords Candida, thyme, and essential oil yielded 22 articles,
but when the date was adjusted to the last 5 years, there were only two articles, and
neither were selected. The next search for Candida and oregano from the last 5 years
resulted in one article that related to the research topic. The additional search for
Candida and lemongrass also revealed one article that was relevant to the research.
Although multiple articles with Candida and essential oils have been published in the
past 5 years and even more in the past 10 years, there were few articles of research
published using any of the three essential oils used in this study. Essential oils tested
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against Candida are common; however, as traditional treatment methods become less
viable, alternative solutions could become more acceptable for common treatment
practice. The remaining articles were found while working in a large teaching hospital
and in the reference sections of other articles.
Articles were chosen based upon topics that included inhibition of Candida
virulence factors, research on how antifungal medications target yeast cell walls,
investigations of essential oils and their antifungal properties, synergy of essential oils
and antimicrobials, and interaction of Candida virulence factors with the host response.
Additional articles relating to potential risk factors for Candida bloodstream infections in
adults were also reviewed. Articles were excluded for review if the organisms tested
were only quality control organisms and did not include patient acquired organisms, if the
methods section was too limited to determine testing validity, or if the articles were not
peer reviewed.
Theoretical Framework
Theoretical frameworks included in this chapter include theories such as the
immuno-epidemiological theory of host interaction with antimicrobial medicine and
infectious microorganisms. Adaptive genetic theory was also used in studies where the
researchers were investigating mutations and the ability for the organism to respond to
stressors to promote organism survival (Ene et al., 2012). In addition, researchers have
developed multiple theories that provide a framework for experimental studies, such as
the germ theory from Pasteur that is based upon the knowledge that microorganisms
cause infectious diseases; Koch built on the germ theory, but further elaborated to
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identify the correct organism that causes a disease, a set of criteria must be met in order
to conclude that the organism causes the disease; and the metabolic control theory where
a set of genes in a linear processing chain inside the microorganism can be used to predict
epistasis in antibiotic resistance (MacLean, 2010).
Although previous researchers may have different frameworks for the foundation
of the study, these theories can all be related to the epidemiologic triangle. The
epidemiologic triangle is a model that is based on the understanding that disease does not
occur randomly throughout a population; rather, certain members of this population may
have an increased risk for a disease that does not just randomly occur throughout the
population (Soumpasis et al., 2015). The triangle can also be useful to identify increased
risk factors for development of diseases in these subpopulations (CDC, n.d.). This type
of causation model is composed of a susceptible host, an external agent, and the
environment in which the host and the agent are in contact with each other (Orr, 2005).
Contact within the host’s environment provides the mode of transmission of the
infectious agent into the susceptible host (CDC, n.d.). Assessment of this interaction is
necessary to develop public health control measures for infectious diseases (CDC, n.d.).
This triangle of interaction has been used to research modes of transmission of
Clostridium difficile that traditionally had been found only in patients who had been
hospitalized but is now commonly found in community settings. The way to interrupt
this disease process is to decrease the likelihood of the organism from being transferred
into new environments from infected or carrier hosts (Gupta & Khanna, 2014). This type
of transmission interruption could also be used to study ways to prevent disease
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formation from Candida albicans in susceptible hosts. Interventions that interrupt the
environmental factors associated with the risks of otitis media, such as nutrition, air
quality, and housing could decrease the incidence of otitis media in children in the
Northern areas of Canada (Orr, 2005). Interventions that prevent host access of Candida
albicans by creating an environment that does not support growth or development of
virulence factors would also disrupt the potential for disease. Soumpasis et al. (2015)
used the epidemiologic triangle to evaluate the use of extended wear contact lenses, the
host’s hygiene, and the risks associated with the development of opportunistic corneal
infections with Pseudomonas aeruginosa. Soumpasis et al. reported that there is
significant overlap between the three components of the triangle, and intervention targets
should be dependent upon whether the focus is epidemiologic investigations, risk
assessments, or therapeutic treatments. From an epidemiological perspective, the focus
of an epidemiologic triangle model is to target disease transmission. This includes
factors in the host that increase susceptibility to disease, primary factors that promote the
organism to cause disease, and proposed measures to control or reduce the incidence of
disease (Soumpasis et al., 2015).
Infections with Candida are thought to be caused by the organisms that naturally
reside on or in the host. Prevention of the formation of virulence factors in Candida
albicans could reduce the risk of acquiring an infection from residing organisms (CDC,
2013). Other areas thought to act as a reservoir for Candida are fomites and hands of
health care workers (Hota, 2004). Candida albicans has been shown to survive on metal
and glass surfaces for 3 days and on cotton and cotton-polyester blend fabrics for at least
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14 days; on human finger pads, 20% of the viable organisms remained detectable an hour
after initial inoculation (Traore, Springthorpe, & Sattar, 2002). The environment for
Candida albicans can be on or in the host itself or merely on the inanimate environments
that the host has contact with regularly. Breaking the transference of the organism by
disrupting the ability to survive in the host environment could disrupt the transmission of
disease and prevent infections. The way to interrupt this disease process is to decrease
the likelihood of the organism from being transferred into new environments from
infected or carrier hosts (Gupta & Khanna, 2014). This type of transmission interruption
could be used to study ways to prevent disease formation from Candida albicans in
susceptible hosts. Interventions that prevent host access of Candida albicans by creating
an environment that does not support growth or development of virulence factors would
also disrupt the potential for disease.
Using a framework of the epidemiologic triangle for the research provided a
foundation of an immunocompromised host, which can be placed into the susceptible
host vertex, Candida albicans, which is placed at the agent vertex, and the environment
which is at the third vertex of the triangle. In this study, I investigated potential means to
disrupt the triangular interaction by breaking one of the sides of the triangle that would
prevent the disease formation. In addition, the component relationships that enables
disease to occur was also used for interpretation of the results from the study. This
potential to inhibit virulence factors could prevent the agent from entering and causing
disease in the host. Another potential place for disruption could involve prevention of the
agent from replicating and surviving in either the host or the environment. I studied ways
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to decrease Candida albicans’s ability to cause disease by examining the prevention of
virulence factor development and yeast cell inhibition or death as well as risk associated
with the covariates age, gender, race, and comorbidities.
Risk Factors Associated with Bloodstream Infections
Yang et al. (2014) performed a retrospective analysis of the epidemiology of 121
Candida bloodstream infections and determined that advanced age and neutropenia were
independent risk factors for mortality within 28 days of initial occurrence of Candida
bloodstream infections. Over 95% of all patients with hospital acquired Candida sepsis
between 2008 and 2012 had at least one comorbidity, and 56% of these patients had two
or more comorbidities (Yang et al., 2014). Although internal medicine wards had higher
28-day mortality rates than surgical wards or intensive care units (ICU), Yang et al. did
not further investigate this angle for infection but did comment that there was poor
compliance to antifungal therapy in some of the wards. Yang et al. also noted that
appropriate antifungal treatment reduced the likelihood of patient death within the first 28
days of infection. Yang et al.’s research sample size and institution were comparable to
this study’s sample size and type of hospital; however, the differences that may occur in
United States hospitals have not been studied. Inclusion of patient covariates such as age,
gender, race, and comorbidities could add knowledge to the body of literature about risk
factors for Candida albicans bloodstream infections.
Kaye et al. (2011) examined 830 patients with bloodstream infections and
compared them to 830 patients without bloodstream infections in the age group 69 to79
years; the predictors of bloodstream infections by any organism were male gender,
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obesity, and a central venous catheter present upon admission. Other predictors included
gastronomy, surgery, and previous hospital exposure (Kaye et al., 2011). The
predominant organism isolated through this study was Methicillin-resistant
Staphylococcus aureus (MRSA), and additional interventions were suggested that would
target elderly males (Kaye et al., 2011). Although this research was used for overall
bloodstream infections, not just Candida albicans infections, it can be used as a
foundation to investigate whether the risk for Candida bloodstream infections are similar
to other types of bloodstream infection risks.
Shigemura et al. (2014) performed a retrospective study of 110 Candida
bloodstream infections over a 5-year period. Shigemura et al. determined that
cardiovascular disease and having a recent surgery increased the risk of Candida albicans
infections; however, chemotherapy and cancer increased the risk of Candida nonalbicans species. In this study the majority (71%) of patients with Candida albicans
bloodstream infections were male, but 62% of the septic patients were under the age of
70 (Shigemura et al., 2014). Hu et al. (2014) examined data of 294 patients and
evaluated the potential risk factors for catheter-related Candida bloodstream infections
(CRCBSI). The risk factors were determined to be age and low body weight (Hu et al.,
2014). However, in this study, Candida parapsilosis caused more CRCBSI and Candida
albicans caused more non-CRCBSI (Hu et al., 2014). Males accounted for the majority
of these bloodstream infections with 75% of the CRCBSI and 68% of the non-CRCBSI
(Hu et al., 2014). Although the central venous catheter (CVC) placement rate was
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highest (89.7%) in patients with CRCBSI, patients with non-CRCBSI had a CVC
placement rate of 81.9% (Hu et al., 2014).
Central-venous catheter placement was also found in 93% of patients with
Candida bloodstream infections in a prospective study of 157 patients (Rajendran et al.,
2016). Age was associated with increased mortality, and 47% of the 30-day mortalities
were in patients with Candida albicans bloodstream infections (Rajendran et al., 2016).
There was a higher mortality rate associated with Candida albicans than with Candida
glabrata infections (Rajendran et al., 2016). In addition, there was a higher mortality rate
for patients whose Candida albicans isolates were shown in laboratory testing to be high
biofilm formers than isolates that were shown to be low biofilm formers (Rajendran et al.,
2016). Removal of a CVC after the detection of a Candida bloodstream infection
improved the clinical outcome of the patient (Rajendran et al., 2016). In a 6-month
retrospective study of bloodstream infections from 2009 of 468 positive blood cultures,
Chander, Singla, Sidhu, and Gombar (2013) showed that 5.79% were Candida isolates;
however, in this study, the most common Candida recovered was Candida tropicalis.
Candida bloodstream infections were associated with broad spectrum antibiotic use
91.6% of the time and associated with CVCs 83% of the time. These infections were
nosocomial and occurred within 48 hours of admission (Chander et al., 2013). Almost
89% of candidemia were recovered from patients in the ICU (Chander et al., 2013). ICU
patients usually have failed host defenses due to underlying disease or an
immunocompromised state (Chander et al., 2013). Although these epidemiological
scholars indicated a higher risk in males, other demographics and comorbidity risk
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factors were not as consistent throughout the studies. This may be due to differences of
predominant infections in various countries; however, additional studies used to examine
risk factors for adult patients seen in the United States to provide additional means for
reducing these factors in the high-risk patients. This type of study may provide insight on
protection measures that could also be used in immunocompromised patients.
Immunocompromised Patients, Infections, and Prophylactic Treatments
Immuno-competent hosts can respond to the invasive hyphal and psuedohyphal
forms of Candida through pathogen recognition receptors (Lewis et al., 2012). These
receptors initiate adaptive immunity in the host that starts the inflammatory response to
contain and destroy the invading organisms (Lewis et al., 2012). However, when an
immunocompromised host becomes infected with Candida, the ability of the host’s
immune mechanisms to respond is diminished, and the potential for serious invasive
infections increases (Lewis et al., 2012). The increase of at-risk populations with lifethreatening fungal infections has also caused an increase in the fungus species that are
considered pathogenic. The most common invasive fungal diseases are caused by
Aspergillus fumigatus and Candida albicans (Alcazar-Fuoli & Mellado, 2014).
Complications to successful treatment include the difficulty in correctly identifying a
fungal infection, as well as the increasing resistance of these organisms to antifungal
medications (Alcazar-Fuoli & Mellado, 2014). Although these types of infections can be
difficult to manage due to the extended time it can take for antifungal medications to
inhibit or kill the organism, there have been improvements in treatment methods and
protocols (Alcazar-Fuoli & Mellado, 2014). However, acquired drug resistance in
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Candida species is complex, and additional information on how the immune system
responds to these resistant organisms may provide improved understanding on the
interactions of virulence factors and drug resistance (Lewis et al., 2012). Providing
alternative options that do not need host immune responses intact or treatments that do
not depend on the same pathways into the yeast cells to disrupt virulence or cause cell
death could enable better outcomes in high risk patients who are immunocompromised.
Developing additional treatment options could minimize the impact of virulence and drug
resistance in yeast cells.
Virulence and Resistance
Severity of Candida infections is correlated with higher virulence factors.
Virulence factors in microorganisms can trigger immune responses in the host (Williams
et al., 2013). When Candida albicans did not produce virulence factors, infections were
generally less severe and less likely to be invasive (Bliss et al., 2012). Interruption of
these virulence factors could improve patient outcomes (Bliss et al., 2012). Virulence
factors include germ tube or pseudo-hyphae production that helps the organism to invade
the mucosal lining and establish the organism to withstand competition from normal flora
inhabiting the mucosal membrane (Bliss et al., 2012). This type of filamentous growth
can be reversed back to unicellular forms based upon stress from the host environment, as
well as the pH of the site of infection (Calderone & Fonzi, 2001). Other virulence factors
that increase pathogenicity of Candida albicans include biomolecules known as adhesins
that are found on the yeast cells wall that promotes binding to the host cells (Calderone &
Fonzi, 2001). Candida albicans can also produce phosolipases and secreted aspartyl
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proteases, which are enzymes that are needed for invasive disease development
(Calderone & Fonzi, 2001). These types of virulence factors can increase mortality rates
by making the infectious process more severe and increasing the yeast cell ability to
evade host responses (Bliss et al., 2012).
Another key component for virulence is the production of biofilms. Biofilms are
communities of organisms that have adhered to a biological or inert surface and formed
an extra-cellular matrix that hold the multi-cellular community together (Lopez,
Vlamakis, & Kolter, 2010). Candida albicans can be found in biofilms both as pseudohyphal and hyphal forms; this combination of forms is thought to contribute to the
development of Candida albicans biofilms as well as conferring increased resistance to
antifungal medications (Watamoto et al., 2009). Candida albicans biofilms have been
shown to be up to 500 times more resistant to the polyene class of antifungals (such as
amphotericin B) and the echinocandin antifungal drug, caspofungin, than high-density
growth of planktonic (free floating, single cell type) cultures (Watamoto et al., 2009).
This propensity for Candida albicans to produce biofilms increases the time that
antifungal medications need to be taken and increases the chance that some of the
organisms in the biofilm can develop resistance to the treatment and thus continue to
replicate and survive in the host causing additional stress to the host systems (Watamoto
et al., 2009). Antifungal medication classes have different methods of inhibition and
actions to destroy yeast cells. Candida albicans survival mechanisms can inhibit these
functions of the different antifungal drug mechanisms. Exploring components to add to
the treatment of Candida infections could lower drug resistance and reduce treatment
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failures through prevention of the organisms’ resistance mechanisms. The known modes
of action of the classes of antifungal medications are discussed below.
Amphotericin B has been shown to interact with the ergosterols in the yeast cell
wall producing tiny channels that cause the potassium and magnesium to leak from the
inside of the cell which then promotes the loss of the proton gradient of the cell wall
(Watamoto et al., 2009). In addition, the disruption of the ergosterol production prohibits
the organism from developing hyphal forms thus reducing its virulence capabilities
(Lewis et al., 2012). Candida albicans biofilm researchers have suggested that the
mechanism of maintaining membrane fluidity in mature biofilms relies less on ergosterol
than younger biofilms and planktonic cultures which makes amphotericin B as well as the
azole class of antifungal medications less effective for treatment of organisms from
mature biofilms (Mukherjee, Chandra, Kuhn, & Ghannoum, 2003). This type of
resistance mechanism that changes the permeability of the cell membrane can reduce the
ability for amphotericin B and fluconazole to enter the Candida cells thus causing
treatment failure (Mukherjee et al., 2003).
The echinocandin class of antifungal medications, including caspofungin, are
fungicidal and inhibit the synthesis of a primary cell wall structural component, 1,3-β-Dglucan (Bachmann et al., 2002). Caspofungin has been shown to reduce the formation of
Candida albicans biofilms as well as causing mutations and decreasing hyphal
formations in established biofilms (Bachmann et al., 2002). However, researchers from a
multicenter surveillance program have indicated that recent exposure to caspofungin in
patients increased the likelihood of being infected with a Candida species with a higher

31
minimum inhibitory concentration (MIC) to caspofungin in laboratory testing including
isolates of Candida albicans and Candida tropicalis which both generally have lower
MIC levels for caspofungin (Lotholary et al., 2011). This increasing resistance to
caspofungin, while still rare in Candida albicans, has caused researchers to focus on
mechanisms in the organism that creates this resistance (Sanguinetti et al., 2015).
The azole class of antifungal drugs (which includes fluconazole) inhibit mycelial
growth by interrupting ergosterol biosynthesis which is a major component in the
production of the plasma membrane of the cell (Ha & White, 1999). Thus, the organism
is more sensitive to azoles during the mycelial phase than the yeast phase due to the
increased need of plasma membrane for hyphal growth during the mycelial phase (Ha &
White, 1999). Azole resistance in Candida albicans isolates can be caused by several
mechanisms with the primary cause of resistance being contributed to drug efflux pump.
Overexpression with other mechanisms such as altering the plasma membrane, changes
to the synthesis of ergosterol, and drug uptake all possibly contribute to the decrease in
susceptibilities of other antifungal medications (Cernicka & Subik, 2006). Acquired
amphotericin B resistance is thought to be caused by alterations in the production of
ergosterol in the plasma membrane and by the organism’s ability to produce catalases
which minimize oxidative damage caused by the antifungal medication (Lewis et al.,
2012). Widespread prophylactic use of fluconazole has contributed to changes in the
epidemiology of Candida infections invoking the selection of increasingly more resistant
strains causing infections (Sanguinetti et al., 2015). These types of acquired resistance
can occur through gene mutations and altered gene expression (Sanguinetti et al., 2015).
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Candida species resistance to echinocandins is generally associated with gene
mutations of the 1,3-β-D-glucan synthase complex (Lewis et al., 2012). However, the
ability of echinocandins to expose β-glucans hidden underneath mannoproteins can still
induce an immune response which during treatment, may prevent the emergence of
subpopulations that acquire resistance (Lewis et al., 2012). However, exposure to higher
concentrations of echinocandins than the MIC level can cause Candida albicans to
increase production of chitin and glucan which can cause an increase in tolerance to
echinocandins which in turn could also inhibit the host’s immune response (Lewis et al.,
2012). Kurtz et al., had previously concluded that these mutant strains of Candida
albicans that are resistant to echinocandins are however, less virulent due to impairment
of germ tube production (1996). In addition, virulence can also be influenced by the
utilization of different carbon sources by Candida albicans (Ene et al., 2012).
Alternate carbon sources such as lactic acid can affect the cell wall synthesis,
hydrophobicity, virulence, and resistance to antifungal treatments (Ene et al., 2012).
Lactic acid can be found in various niches in the human body including the
gastrointestinal and urogenital tracts through the body’s metabolic activity on ingested
food and produced by bacteria commonly found in these areas (Ueno et al., 2011). In
laboratory testing, Candida albicans isolates grown on lactate media had a thinner cell
wall with a marked decrease of chitin and β-glucan when compared to isolates grown on
a glucose enriched media (Ene et al., 2012). In addition, the lactate grown cell wall had a
two-fold increase in porosity and showed a higher propensity to be hydrophobic than the
glucose grown cells (Ene et al., 2012). The lactate grown Candida albicans also
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exhibited a stronger adhesion to plastics than the isolates grown in the presence of
glucose (Ene et al., 2012). This ability to adhere is a virulence trait that has a major role
not only in biofilm production on medical devices but also contributes to tissue
colonization (Calderone & Fonzi, 2001). In addition, lactate grown cells were more
resistant to high salt concentrations and the cell walls were more rigid indicating an
increased ability for the cells to penetrate the epithelial cells and establish pathogenic
residency in the host (Ene et al., 2012).
With the reduction of β-glucan and chitin in the thinner cell wall, lactate grown
Candida albicans were more resistant to caspofungin and amphotericin B (Ene et al.,
2012). Cells grown with glucose were more sensitive to amphotericin B and had less
tolerance to osmotic stress compared to lactate grown cells (Ene et al., 2012). Virulence
factors can therefore also be affected by the carbon source (such as lactate or glucose)
that is used by Candida albicans. The carbon utilization pathway has been shown in
mouse models to be dependent upon the site of infection and which carbon source is in
higher abundance (Ene et al., 2012). The immune system in an immunocompetent host
contains additional antimicrobial fighting agents that can still respond to the invasion
regardless of the location of the infection (Mehra et al., 2013). Host defenses cannot
respond adequately to infections when the immune system has been inhibited. Healthy
host defenses and integrative treatment options will be discussed in the next section.
Alternative Treatment Options and Host Defenses
Bacteria, fungus, and viruses can be directly killed through a component of the
innate immunity known as antimicrobial peptides (AMPs) which attacks the organisms
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through immunomodulation or inhibiting virulence factors (Mehra et al., 2013). AMPs
can also synergistically interact with intact mucosal epithelial cells to prevent pathogenic
invasions (Mehra et al., 2013). The antifungal peptides have different microbial targets
than antifungal medications which has caused investigators to study laboratory
production of these AMPs as an alternative method for treating fungal infections (Mehra
et al., 2013). Topical treatments however appear to hold the most promising application,
not systemic treatments therefore, other treatment options for systemic infections are still
needed (Mehra et al., 2013). Other researchers have targeted the potential use of
defensins which are a specific group of AMPs found in a large majority of eukaryotic cell
types (Silva, Goncalves, & Santos, 2014). Defensins have antimicrobial properties but
also can affect the functions of the immune system to protect the host from invading
pathogens (Silva et al., 2014). Defensins can attack the microbial cell wall and disrupt
the activation of virulence factors (Silva et al., 2014). While defensins can efficiently
react to fungus and yeast, the serum half-life of these peptides is low and the treatment
for invasive infections may also be limited (Silva et al., 2014). In an
immunocompromised patient, the body cannot produce enough AMPs and the technology
to increase the ability for the defensins to be viable for treatment in yeast systemic
infections remains elusive therefore other options still need to be investigated. Even in
immunocompromised patients however, the initial immune response starts with the
epithelial cells.
Host epithelial cells respond differently to commensal Candida compared to
infectious Candida (Williams et al., 2013). Mucosal epithelial cells comprise a first line
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of defense against microorganisms and will respond differently to an organism based
upon its production of virulence factors (Williams et al., 2013). Organisms will produce
these virulence factors as a method of survival (Williams et al., 2013). Virulence factors
trigger the host immune response and prevention of virulence factor production could
prevent infections from occurring (Williams et al., 2013). Additional protective defenses
in the mucosal tissue of the upper and lower respiratory tract include antioxidant
capabilities that can reduce pulmonary inflammation. Enhancement of these protective
mechanisms can also reduce tissue damage, immune responses, and the development of
debilitating illnesses (Gao et al., 2011). Without an adequate immune response, however,
protection from severe infections is limited and the risk of environmental exposure and
subsequent infections caused by Candida albicans somehow needs to be reduced.
Different methods of investigating treatment options using various plant derived oils have
been studied.
Researchers utilized naturally occurring oils to strengthen the antioxidant and
anti-inflammatory response in nasal mucosal epithelial cells of 12 healthy adults to
evaluate a way to improve protection against infections in the lower airways (Gao et al.,
2011). The combined mixture of aloe, orange, peppermint, coconut, and vitamin E, in a
carrier oil of soy, reduced inflammation when volunteer test subjects were exposed to
ozone (Gao et al., 2011). The ozone was intended to mimic endotoxin production when
an organism invades the mucosal membrane. The authors extrapolated that the results
could indicate that the combined oils could prevent infections from occurring by
inhibiting pro-inflammatory actions of the immune system that occur from microbial
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endotoxin production exposure (Gao et al., 2011). While this research provides an
interesting foundation for additional studies, the test sample was small, and the healthy
adults may respond differently with ozone exposure than immunocompromised patients
that are at an increased risk of severe infections.
Other immune response mechanisms include the production of oxidative stress
which has been shown to destroy microorganisms through the disintegration of the cell
membrane (Khan et al., 2011). Production of oxidative stress using the phenylpropanoid
chemical compounds, estragole, methyl eugenol, and eugenol that are found in essential
oils, substantially destroyed Candida albicans in laboratory testing (Khan et al., 2011).
This type of oxidative stress is independent of the host immune response and could be
useful for patients that are immunosuppressed. While minimum inhibitory
concentrations (MICs) of these compounds have previously been shown to disrupt
membrane integrity and therefore cause fungal cell death, sub-MIC levels were also
shown to severely damage the defense mechanisms of Candida albicans which ultimately
also resulted in fungal cell death (Khan et al., 2011). The potential for naturally
occurring chemical compounds found in plants to be used as antifungal treatments that
are not dependent on an intact immune system and do not interact with the areas targeted
by antifungal drugs provides additional areas for research to improve patient health
outcomes and reduce mortality risks. Research involving interactions of various essential
oils and fungus and yeast isolates will be discussed in the following section.
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Essential Oil Treatments for Fungus and Yeast
Fenugreek (Trigonella foenumgraecum), cinnamon (Cinnamomum verum),
papaya (Carica papaya), oregano, and garlic all contain phytochemical compounds
known to have anti-mycotic activity (Varadarajan, Narasimhan, Malaisamy, &
Duraipandian, 2015). Fenugreek, cinnamon, and papaya extracts were evaluated for
activity against fluconazole resistant Candida albicans with zones of inhibition measured
and the percentage of inhibition was then calculated (Varadarajan et al., 2015). The
MICs were calculated per standard protocol and all 3 extracts were shown to have antimycotic activity with an MIC of 15.62 µg/ml (Varadarajan et al., 2015). Several
chemical compounds found in these extracts are known to inhibit proteins and enzymes
that are essential for cell wall survival of both bacteria and fungus (Varadarajan et al.,
2015). Other essential oils such as black cumin, curry, ajwain, and betel leaf were tested
against Candida albicans, Candida tropicalis, Candida glabrata, and Candida
parapsilosis (Rath & Mohapatra, 2015). Ajwain and black cumin had the highest level of
activity against the yeast by causing irreversible cell damage which led to subsequent cell
death and the oils still maintained this activity after heat treatment and autoclaving (Rath
& Mohapatra, 2015). Mechanisms of membrane inhibition are thought to be caused by
the ability of the oils to make partitions in the cell membrane which then causes the cell
components to leak out and the organism to die (Rath & Mohapatra, 2015). Various
chemical compounds found naturally in essential oils are thought to be the agents
responsible for the antimicrobial actions of essential oils (Bellete et al., 2012). While
some of the research on essential oils against microbes was with indigenous species of
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plants specific to the researchers’ location, potential for widespread use could be limited.
For this study, oregano, lemongrass, and thyme were chosen based upon not only
previous research that has shown antifungal efficacy for all three oils, but also the
widespread availability of the oils, which in turn could reduce the cost of adding the oils
as treatment. Lemongrass has been shown to also have strong anti-inflammatory
properties (Boukhatem, Ferhat, Kameli, Saidi, & Kebir, 2014), which could potentially
improve a patient’s well-being and comfort. Specific chemical compounds for the
essential oils in this study will be discussed in the next section.
Chemical Composition and Mechanisms of Action of Lemongrass, Oregano, and
Thyme Essential Oils
The monoterpene aldehyde, citral, which is comprised of neral and geranial, is
found in the highest concentration in lemongrass (Cymbopogon species) essential oil
(Shah et al., 2011). Other major components include the terpenes limonene and myrcene
(Shah et al., 2011). Citral, thymol, carvacrol, and linalool are all oxygenated terpenes
which have been shown to effectively kill various microbes (Korenblum et al., 2013).
These oxygenated terpenes are thought to produce oxidative stress on the yeast causing
cell death (Khan et al., 2011). The aldehydes are thought by some researchers to have
more effective anti-microbial activity than the phenolic compounds such as thymol and
carvacrol (Marin, Sanchis, & Ramos, 2011). However, other authors have indicated that
the phenols thymol, carvacrol, and eugenol have the highest antimicrobial activity due to
containing an acidic hydroxyl group (Kalemba & Kunicka, 2003). Aldehydes are also
acidic by nature which could make it more difficult for Candida albicans to change the
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environment to a basic pH to induce virulence factors (Shah et al., 2011; Vylkova &
Lorenz, 2014). While there has been speculation that aflatoxins could be produced by
certain fungus in relation to the increase in oxidative stress, the combination of phenols
and aldehydes are thought to act synergistically and could provide alternatives that would
be difficult for fungus and yeast to develop resistance or produce aflatoxins due to
multiple fungi-toxic components (Molyneux, Mahoney, Kim, & Campbell, 2007; Sidhu,
Chandra, & Behl, 2009).
In oregano (Origanum vulgare) essential oil, the major constituents are also
oxygenated monoterpenes, mainly carvacrol and thymol (Teixeira et al., 2013). Pozzatti
et.al, (2008) indicated that carvacrol along with thymol acts synergistically against
Candida albicans and that fluconazole resistant strains appear to be highly susceptible to
oregano. Phenolic and terpene components have also been shown in the host to produce
strong inhibition to pro-inflammatory mediators in such as nitric oxide and reactive
oxygen species (Leyva-Lopez et al., 2016). Nitric oxide (NO) and reactive oxygen
species (ROS) can be utilized by the host to fight infections however, increased amounts
of ROS can also destroy human cells (Brieger, Schiavone, Miller, & Krause, 2012). ROS
tends to transfer an electron to oxygen thus forming a superoxide which in turn can react
with NO to create a highly reactive peroxynitrite (Brieger et al., 2012). This
peroxynitrite in turn has a high toxicity to human cells (Brieger et al., 2012). Reducing
these biochemical reactions from over stimulation could also help the immune system
react to yeast infections more efficiently with less host damage (Leyva-Lopez et al.,
2016). Radical scavenging of essential oil compounds could also increase the synergistic
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activity of combined essential oils (Tepe, Daferera, Sokmen, Polissiou, & Sokmen,
2004).
Like oregano, thyme (Thymus vulagris L.) essential oil also is primarily composed
of the phenolic compounds, thymol and carvacrol (Agili, 2014). Thyme essential oil is
acidic with a pH around a 3.5 (Agili, 2014). An acidic environment inhibits the ability of
Candida albicans to switch to the more virulent hyphal phase (Vylkova & Lorenz, 2014).
Thymols constitutes generally around 50% of the compounds in thyme and carvacrol
makes close to 5% of the components (Agili, 2014). Thymol and carvacrol have shown
synergistic anti-microbial effects when combined in laboratory experiments (Tepe et al.,
2004). Researchers have speculated that the essential oil activity against microbes may
be due to the ratio of the chemical components, not merely by the quantity found in the
essential oil (Kalemba & Kunicka, 2003). This information provides a foundation to
study the use of lemongrass, oregano, and thyme individually and combined for improved
efficacy against Candida albicans isolates. Research on lemongrass, oregano, and thyme
essential oil activity against fungus and yeast will be addressed in the following section.
Activity of Essential Oils Against Yeast and Fungus
While carvacrol can make up 90% of the compounds found in oregano, authors
have indicated that purified constituents at equal concentrations are less effective against
microbes than the original essential oil indicating that the components act synergistically
even in small quantities (Turgis, Han, Caillet, & Lacroix, 2009). This could prevent the
development of antifungal treatments with synthetically developed chemical compounds
used alone. Other potential areas for use of essential oils include dentistry. Tissue
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conditioner is used to promote healing around dental devices however, the conditioner
can become a reservoir for microorganisms including Candida after extended use
(Amornvit et al., 2014). Lemongrass essential oil and nystatin were each mixed with the
tissue conditioner and tested against 10 clinical Candida isolates as well as a quality
control strain (Amornvit et al., 2014). The lemongrass had a calculated MIC level of
0.635 µ/ml but to achieve effectiveness mixed in with the tissue conditioner, a 0.25%
volume, calculated at 4-times the MIC level, was needed due to the viscosity of the tissue
conditioner. Lemongrass was similar to nystatin in efficacy against the Candida strains
tested (Amornvit et al., 2014).
Researchers also investigated the antifungal activities of lemongrass in the
laboratory as well as its anti-inflammatory properties in mice (Boukhatem, Ferhat,
Kameli, Saidi, & Kebir, 2014). The quick acting anti-inflammatory properties of
lemongrass were demonstrated in mice through both topical and oral application
(Boukhatem et al., 2014). The antifungal properties were assessed both in liquid and
vapor phases (Boukhatem et al., 2014). While both phases inhibited fungal isolates, the
vapor phase showed increased efficacy against the fungal isolates and Candida albicans.
This may provide a basis for further studies using different methods of delivery of
essential oil treatments. Lemongrass has been shown to disrupt biofilm formation in
Candida albicans isolates that were known to be able to produce moderate to strong
biofilms and the researchers were unable to increase tolerance to lemongrass by exposing
the Candida albicans isolates to low levels of the essential oil (Sajjad Ahmad Khan &
Ahmad, 2012). This lack of resistance to essential oils promotes the importance to
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further study the use of essential oils against Candida since resistance to the antifungal
medications continues to increase.
Thyme was also evaluated to examine antifungal activities against Candida
albicans and Aspergillus fumigatus (Bellete et al., 2012). Thyme essential oil showed
strong antifungal activity in low concentrations (Bellete et al., 2012). To confirm that
this activity was due to chemical compounds in the oil and not just the use of any oil,
vegetable oil and three additional essential oils (vetiver, wild orange, and argan) with
known minimal antifungal activity were also tested. Increased dilutions of the organisms
were still inhibited with the introduction of thyme (Bellete et al., 2012). Low
concentrations of essential oils needed for antimicrobial activity and the volatile nature of
essential oils provide additional areas for research (Bellete et al., 2012). Additional
researchers compared the activity of cinnamon, lemon, eucalyptus, and thyme compared
to activity of chloramphenicol against Candida albicans, Tricophyton, and Microsporum,
and several bacterial strains (Nasir, Tafess, & Abate, 2015). Thyme had the largest zone
of inhibition upon laboratory testing (Nasir et al., 2015).
Thyme has potential to be used in topical treatment of dermatophytes as well as
other fungal, yeast, and bacterial isolates. Calculated MIC levels were shown to be lower
for thyme than levels needed for chloramphenicol (Nasir et al., 2015). In addition, the
zone of inhibition for thyme against the organisms tested was almost twice as large as the
zone for chloramphenicol (Nasir et al., 2015). Other studies where researchers compared
essential oil activity against Candida species in comparison to amphotericin B and
fluconazole resulted in thyme essential oil having higher inhibitory activity against

43
Candida species than lemon or pennyroyal essential oil (Omran & Esmailzadeh, 2009).
While amphotericin B had a larger zone of inhibition in this study than fluconazole,
thyme exhibited a larger zone of inhibition than either antifungal medication tested
(Omran & Esmailzadeh, 2009). Researchers do admit however, that zone size
comparisons can be difficult to determine rates of effectiveness and further evaluations
are warranted (Omran & Esmailzadeh, 2009). Time-to-kill assays proposed in this study
may provide a more accurate assessment of essential oil activity against Candida
albicans.
While the focus of multiple studies has been on antimicrobial activities of
essential oils other researchers have examined mechanisms of how the essential oils
cause damage and pathogen cell death. Rajkowska, Kunicka-Stycynska, Maroszynska,
and Dabrowska (2014) evaluated the effect that tea tree and thyme essential oils had on
biochemical and enzymatic processes of Candida albicans strains. Extensive loss of the
ability to assimilate different carbon sources occurred in Candida albicans isolates after
exposure to tea tree and thyme essential oils (Rajkowska et al., 2014). This disruption in
enzymatic activity could decrease the pathogenesis of Candida albicans (Rajkowska et
al., 2014). Thyme and tea tree essential oil have also been shown to not only reduce the
activity of enzymes but the ability for Candida to uptake sugars was also inhibited or
prevented (Rajkowska et al., 2014). Monoterpenes such as carvacrol and thymol are
thought to disrupt ATP synthesis reducing regulation of other cellular functions
(Custodio, Ribeiro, Silva, Machado, & Sousa, 2011). Other researchers have also
concluded that Candida species do not appear to be able to develop resistance to essential
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oils in laboratory testing (Budzynska et al., 2013). This inability to develop resistance
could provide additional options for long-term prophylactic use of essential oils to
prevent Candida infections in immunocompromised patients and potentially reduce the
number of drug-resistant Candida in the host environment and therefore improve patient
outcomes and reduce hospitalizations and mortality. In addition, various essential oils are
quick-acting fungicides that have been shown to decrease the ability of Candida albicans
to withstand oxidative stress from the immune system (Budzynska et al., 2013). This
aspect could also benefit immune-competent patients. Other investigations have been
used to evaluate the interactions between essential oils and antimicrobial treatments
which will be discussed in the following section.
Effects of Combining Antimicrobials and Essential Oils
A total of 35 combinations of various essential oils and antibiotics were tested
against three strains of Escherichia coli with four combinations showing high synergistic
effects (Xi Yap, Lim, Hu, & Yiap, 2013). The combinations with the highest effects
were piperacillin/cinnamon, piperacillin/lavender, piperacillin/peppermint, and
meropenem/peppermint (Xi Yap et al., 2013). These combinations could allow for a
reduction in the effective dose of the antibiotics needed which in turn, could decrease the
adverse side-effects of antibiotic treatment (Xi Yap et al., 2013). There were also no
antagonistic effects observed between the essential oils and antibiotics tested, which
would indicate that essential oils do not lessen the effect of the antibiotics and the
antibiotics do not interfere with the effect of the essential oils (Xi Yap et al., 2013). In
addition, the effective combinations could substantially reduce MIC levels in organisms
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that possess plasmid mediated resistance to the antibiotic (Xi Yap et al., 2013). Further
investigations into interactions between antifungal medications and multiple essential oils
have not been extensively studied. Increased resistance to antifungal medications as well
as increased fungal infections due to Candida albicans has also created the need for
researchers to find potential alternative treatment options (Sajjad Ahmad Khan et al.,
2012).
Researchers screened 21 essential oils for activity against drug resistant strains of
Candida albicans (Sajjad Ahmad Khan et al., 2012). Lemongrass exhibited strong
antifungal activity and appeared to be more effective than fluconazole against Candida
isolates tested (Sajjad Ahmad Khan et al., 2012). The eugenol compounds found in clove
oil exhibited high levels of synergy with fluconazole and amphotericin B against drug
resistant yeast strains (Sajjad Ahmad Khan et al., 2012). Eugenol is a phenylpropanoid
and has similar properties to the phenols thymol and carvacrol which are found in
oregano and thyme. Pozatti et al., (2008), concluded that oregano, thyme, ginger, and
cinnamon all express antifungal activities on both fluconazole sensitive and resistant
strains of Candida species. Oregano showed the highest activity against fluconazole
resistant and susceptible strains of Candida which led the authors to suggest that the
antifungal activity of oregano is not dependent upon changes in Candida that are
associated with fluconazole resistance (Pozatti et al., 2008). Due to the higher activity of
oregano compared to thyme, the authors concluded that carvacrol could be the main
constituent responsible for the antifungal activity (Pozatti et al., 2008). In comparison,
the fluconazole resistant Candida albicans and Candida dubliniensis were more sensitive

46
to thyme than the fluconazole sensitive counterparts which the authors concluded may be
due to the combined activity of the chemical compounds found in the oils tested or that
the resistance mechanisms could make the organisms more susceptible to the impact of
the essential oils (Pozatti et al., 2008). Other studies on various thyme species have led
researchers to conclude thyme essential oils showed a stronger synergy with fluconazole
than amphotericin B against Candida species (Saad et al., 2010).
While tea tree oil and its chemical components were tested against 100 Candida
isolates and shown to be effective against biofilm forming strains (Ramage et al., 2012),
additional researchers investigating the activity of lemongrass essential oil against the
formation and reduction of pre-formed Candida biofilms have also indicated that while
these laboratory-created biofilms have shown increased resistance to antifungal drugs, the
biofilms displayed no tolerance to lemongrass (Sajjad Ahmad Khan & Ahmad, 2012).
Cancer patients are at increased risk of oral Candida infections due to the formation of
these biofilms which then increases the risk of invasive infections (Ramage et al., 2012).
Utilizing lemongrass to reduce oral biofilms could interrupt the reservoir for invasive
infections of Candida and disrupt the epidemiologic triangle. Lemongrass was also
shown to cause deformities in the 3-dimensional structures of the biofilms, even at subMIC levels (Sajjad Ahmad Khan & Ahmad, 2012). In addition, there was a 60%
reduction of viable sessile cells of Candida within 12 hours of exposure to lemongrass
but not with fluconazole or amphotericin B even after 48 hours (Sajjad Ahmad Khan &
Ahmad, 2012). The authors concluded that the ability for lemongrass to prevent biofilm
formation may provide alternatives to pre-treatment of devices as well as a reduction in
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toxicity load to the patient (Sajjad Ahmad Khan & Ahmad, 2012). Reduction of toxicity
of antifungal medications to improve patient outcomes has previously been discussed
however, questions about potential of toxicity of essential oils to human cells will be
discussed in the next section.
Evaluation of Host Cell Toxicity from Essential Oils
A potential concern for utilizing essential oils for treatment in patients is whether
the essential oils are also toxic to human cells. Agili (2014) investigated the effects of
thyme on three types of cancer cells lines as well as a non-tumor human cell line grown
in the laboratory. While the thyme inhibited the tumor cell growth by 50%, the essential
oil had no cytotoxic effect on the non-tumor cell line PLP2 even at concentrations higher
than 450 µg/ml (Agili, 2014). Sinha, Jothiramajayam, Ghosh, & Mukherjee (2014)
evaluated the potential toxic effects of lemongrass, palmarosa, citronella, and vetiver
against human lymphocytes in cell cultures. The authors reported that while the essential
oils tested were cytotoxic at 1000 µg/ml, this is over 100 times the amount needed to
have an antifungal effect on yeast and fungus (Sinha et al., 2014). The MIC range for
essential oils to kill yeast and fungus is normally between 0.2 and 10 µg/ml (Sinha et al.,
2014). The authors concluded that lemongrass, palmorosa, citronella, and vetiver would
be safe for human consumption at lower levels (Sinha et al., 2014). The essential oils in
the Sinha et al. (2014) study were purchased through Sigma-Aldrich Chemical which
may not provide high quality naturally derived plant oils and could therefore limit the
toxicity results for the study.
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Variances in study designs and essential oils tested were not always evaluated
using standardized methods. For example, some researchers distilled the essential oils
from dried plant material stored at various temperatures for various lengths of time
(Agili, 2014; Bellete et al., 2012; Boukhatem et al.; 2014; Cleff et al.; 2010; Teixeira et
al., 2013) and others purchased oils or chemical compounds from a vendor (Omran &
Esmailzadeh, 2009; Pozatti et al.; 2008; Rajkowska et al.; 2014, Sajjad Ahmad Khan et
al., 2012; Xi Yap et al., 2013). With the variety of distilling techniques and storage
stability used in the reviewed research, there could be a potential to not be able to
reproduce the results that were reported or for similar research to publish different results
on the effectiveness of different essential oils against Candida isolates. To minimize
result errors due to inconsistencies in the quality of the essential oils tested, the essential
oils used for this research were all purchased from a known high-quality vendor,
doTERRA International. Each batch of essential oils are tested using gas
chromatography and mass spectrometry to evaluate the chemical compounds found in
each oil. In addition, the oils are further tested using Fourier Transform Infrared
Spectroscopy (FTIS) to ensure potency and consistency between each batch, chirality
testing which verifies that there are no synthetic components found in the oils, heavy
metal testing to ensure there are none present, and microbial testing to verify there is no
contamination of bacteria, fungus, or viruses (doTERRA CPTG Certified Pure
Therapeutic Grade Quality Testing website, 2016). The chemical components from each
oil tested will be provided by the vendor to improve comparability with previous test
results. The results of this study filled in the gap of utilizing combined essential oils as
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well as combined essential oils with antifungal medications. This research also provided
a foundation and direction for additional research. Further information concerning the
methods employed in the reviewed articles are discussed in the next section.
Methodology Review
Increased drug resistance of fungus, yeast, and bacteria due to higher numbers of
immunocompromised patients who are at high-risk for infection, have caused researchers
to investigate potential alternative treatment options. Candida albicans is the second
leading cause of fungal infections worldwide and this disease burden is likely
underestimated due to misdiagnosis and lack of required reporting for all invasive fungal
disease except for Coccidioides which causes Valley Fever (Brown et al., 2012). Most
studies reviewed used a quasi-experimental design not an experimental design due to lack
of randomizing the organisms studied (Amornvit et al., 2014; Bellete et al., 2012;
Boukhatem et al., 2014; Gao et al., 2011; Khan et al., 2011; Lewis et al., 2012). Most of
the research reviewed were performed primarily in laboratory-controlled settings.
Several of the studies were case reports based on infectious disease outcomes when
patients were infected with Candida (Alcazar-Fuoli & Mellado, 2014; Brown et al.,
2012). Other research methods were a combination of case reports of patient outcomes
and using organisms isolated from patient infections in experimental laboratory testing
(Bliss et al., 2012). This section is used to review the methodology that was used to
evaluate essential oils, antifungal medications and the interactions with various
organisms.
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Several of the studies performed used novel approaches to test interactions and
some studies had very detailed methodology that could easily be expanded upon for
future research (Omran & Esmailzadeh, 2009; Rajkowska et al., 2014; Sajjad Ahmad
Khan & Ahmad, 2012). Some researchers attempted to address in-vivo issues using
human cell lines and mouse models (Ramage et al., 2012; Sajjad Ahmad Khan et al.,
2012). One study had human participants to study the ability of reducing nasal passage
inflammation after ozone exposure using essential oils however, this study was small and
used healthy individuals (Gao et al., 2011). All the experimental studies either had
replicated sample testing multiple times or had large sample sizes to protect validity and
reliability.
Evaluation of the potential covariates and risk factors were done using
retrospective studies (Chander et al., 2013; Shigemura et al., 2014; Yang et al., 2014), a
retrospective case-control study (Kaye et al., 2011), and prospective studies (Hu et al.,
2014; Rajendran et al., 2016). The researchers in these studies reported on different risk
factors or predictors but other information could also be acquired about some of the
patient demographics however, race as a covariate was not discussed in any of the articles
mentioned. Race has previously been shown to be a factor in other health risks (Frieden,
2011) therefore, the inclusion of race in evaluating risk factors for Candida albicans
bloodstream infections may provide additional insight for prevention measures. The
conclusion of this literature review will be discussed in the next section.
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Conclusion
Increased numbers of long-term immunocompromised patients provide ample
environments for opportunistic pathogens to infect patients and for well recognized
pathogens to acquire higher levels of drug resistance. With limited anti-microbial
medications available, acquired drug resistance especially in yeast such as Candida
require new and different approaches to successfully treat these patients (Silva et al.,
2014).
Novel options such as synthesis of naturally occurring antimicrobial proteins
(AMPs) provide an exciting potential for treatment however, the short half-life of the
proteins pose potential delivery issues in the patient as well as stability of the proteins to
maintain efficacy while being stored or manufactured (Mehra et al., 2013). Candida
albicans produce virulence factors that disrupt the mucosal epithelial surfaces which can
allow for the yeast to create serious and life-threatening infections (Lewis et al., 2012).
Preventing these virulence factors from forming could also improve patient outcomes and
reduce the risk of serious infections (Bliss et al., 2012). Alternative options for treatment
of Candida infections include the investigations of utilizing antimicrobial peptides
(AMPs) for interrupting the disease process (Mehra et al., 2013). While AMPs show
promise at being able to kill various microorganisms, the half-life is very limited in
serum and these treatment options may not prove beneficial for invasive infections (Silva
et al., 2014). One type of AMP, known as defensins, have also shown promise to reduce
virulence in yeast and fungus and have been shown to be able to kill the organisms,
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however, the ability to get the defensins to the infection site may prevent widespread use
other than topical treatments (Silva et al., 2014).
Virulence factors in microorganisms can trigger immune responses (Williams et
al., 2013). Pathogen recognition receptors (PRR) can initiate immune responses to
invading yeast. Immune defenses can also include antioxidant activity in the mucosal
tissues. Essential oils can increase antioxidants that are responsible for the reduction of
pro-inflammatory toxins released by microorganisms that cause infections (Gao et al.,
2011). Phenylpropanoid compounds found in various essential oils destroy Candida
through oxidative stress and subsequent cell wall destruction in laboratory testing (Khan
et al., 2011). Extracts of fenugreek, cinnamon, and papaya have all shown anti-mycotic
activity by inhibiting proteins and enzymes needed for cell wall survival in bacteria and
fungus (Varadarajan et al., 2015). In addition, other research has shown that tea tree oil
can not only prevent biofilms caused by Candida isolates but also reduce inflammatory
response in host tissue (Ramage et al., 2012). Black cumin, curry, ajwan, and betel leaf
showed strong activity against various Candida species by causing irreversible cell
damage which in turn caused cell components to leak out. These essential oils also
maintained effectiveness after heat treatment and autoclaving (Rath & Mohapatra, 2015).
While many essential oils have been evaluated as alternative treatment options, some are
only available at a local level, are expensive to manufacture, or would not be available in
larger amounts on a regular basis. Therefore, lemongrass, oregano, and thyme were
chosen for further study against Candida albicans isolates.
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Lemongrass essential oil treatment showed similar efficacy against Candida when
compared to nystatin treatment of tissue conditioners that are used to promote healing
after dental procedures (Amornvit et al., 2014). Additional studies were used to assess
antifungal properties of lemongrass in both liquid and vapor phases as well as potential
anti-inflammatory properties. The anti-inflammatory treatment was quick acting in mice
and the vapor phase showed higher efficacy against Candida albicans and fungal isolates
(Boukhatem et al., 2014).
Thyme essential oil has also been shown to have strong antifungal activity in low
doses against Candida isolates (Bellete et al., 2012). In comparison of cinnamon, lemon,
eucalyptus, and thyme to chloramphenicol against yeast colonies, thyme had increased
zones of inhibition and lower MIC levels were needed for inhibition of the organisms
tested (Nasir et al., 2015). Utilizing a combination of 35 various essential oils and
antibiotics, additional researchers tested these combinations against resistant strains of
Escherichia coli (E. coli). Four of these combinations had high synergistic effects
against E. coli. These combinations could reduce the amounts of antibiotics needed to
treat infections (Xi Yap et al., 2013). This information could be used to develop
additional studies for treatments against Candida albicans infections. Drug resistant
Candida albicans were also tested against 21 essential oils. Lemongrass exhibited high
antifungal activity and was more effective than fluconazole against these resistant strains
in laboratory testing (Sajjad Ahmad Khan et al., 2012).
Essential oils have been used in remedies for centuries and researchers from all
parts of the world have shown successful inhibition and microbial death with treatments
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using a variety of essential oils against a multitude of organisms in laboratory testing.
Essential oils such as oregano, lemongrass, and thyme have been shown to have
inhibition and cidal capabilities against Candida isolates (Boukhatem et al., 2014).
Added benefits of potential essential oil use for infections are the capabilities for the oils
to reduce inflammation (Ramage et al., 2012).
While it may be difficult to study only essential oil interactions with Candida
infections in human subjects due to a risk for the patient in deviating from standard of
care, the addition of essential oils to standard antifungal treatment methods might prove
to be a successful alternative. The pursuit of evaluating host interactions with essential
oil treatments for infections may be enhanced by additional studies of synergistic
interactions of antifungal medications and essential oils initially in the laboratory
environment.
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Chapter 3: Research Method
Introduction
The purpose of this study was to develop a system to examine the effectiveness of
three individual essential oils (lemongrass, oregano, and thyme) used separately and in
conjunction with each other in the presence of the antifungal medications fluconazole and
caspofungin. These antifungal treatments are recommended for a patient with a Candida
albicans systemic infection (Pappas et al., 2016). A quantitative method was used to
evaluate the impact the use of these oils in combination with antifungal medications had
on the ability to minimize virulence factors and to kill Candida albicans in-vitro.
Repeated and long-term use of antifungal medications has helped to develop
increased resistance to these medications in Candida species (Mehra et al., 2013). This
increased drug resistance has not only elevated the cost for treatment, but also has
increased the risk of mortality from these infections. Limited treatment options and
rising mortality rates in both adults and children infected with Candida necessitates new
methods for treating these life-threatening infections (Zaoutis et al., 2005).
In this chapter, I will review the research design and rationale for using a
quantitative method to examine the interactions of the essential oils lemongrass, oregano,
and thyme with antifungal medications and the impact on known virulence factors of
Candida albicans. The study participants, sampling, study variables, and measurements
used will also be discussed in this chapter. This will be followed by the statistical
analysis methods, as well as the potential ethical concerns of using data obtained from
previously collected isolates.
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Research Design and Rationale
I used a quantitative design to evaluate the impact these oils in combination with
antifungal medications had on the ability to interfere with virulence factors of Candida
albicans; the ability to cause death to the yeast cells; and to evaluate the impact of age,
race, gender, and comorbidities on the risk of Candida albicans bloodstream infections.
Quantitative experimental designs are used to test a cause and effect relationship with
known variables (Frankfort-Nachmias & Nachmias, 2007). The research questions of
whether essential oil treatment can have a positive impact on Candida albicans infections
were best investigated by using a quantitative experimental design. This experiment was
further designed to evaluate the covariates for confounding and risk factors. Using an
experimental quantitative design also enables the researchers to replicate the study to
verify the results or for additional researchers to repeat the study to determine whether
the outcomes are similar (Frankfort-Nachmias & Nachmias, 2007).
For an organism to cause an infection, it must produce virulence factors and
continue to replicate. Antifungal medications attack the organism by various means to
kill the organism or prevent replication of the organism (CDC MASTER website, n.d.).
This process can take an extended amount of time, and the organism may become
resistant to the medication during that time (Bliss et al., 2012). Essential oils have been
shown in previous laboratory studies to stop the organism from producing these virulence
factors, as well as killing these infectious organisms (Cleff et al., 2010).
I investigated the effectiveness of essential oils against Candida infections, as
well as the impact that the oils may have with the host’s immune response, using a

57
deductive methodology to provide alternatives for these resistant organisms. Data were
collected on whether the organism was inhibited or killed using repeat culturing methods
for the organism, as well as investigating any statistical significance based upon the
covariates.
The experimental design allowed for this research to be replicated with additional
population groups or by other researchers (Frankfort-Nachmias & Nachmias, 2007). Use
of this design can also provide a way to assure a high degree of validity due to the ability
to culture each Candida albicans isolate before and after exposure to the essential oils
and antifungal medications, as well as determining whether any of the covariates are
related to increased yeast. Although current researchers provided promising in-vitro
results of the efficacy of essential oils against Candida and its infectious properties, there
are limited treatment options used for Candida infections when the organism has become
resistant to multiple medications (Tyagi & Malik, 2010). With the continued increase in
drug resistance, there have been few published studies aimed at validating the response in
isolates collected from patients in populations being exposed to alternative treatment
regimens. Scholars have investigated different essential oils and their effectiveness
against Candida using various methods to monitor levels needed to inhibit or kill the
yeast cells; however, there has been no standardized testing within a population of
infected patients. This has made it difficult to determine the true effectiveness of
essential oils against Candida infections.
The variables measured in the first five research questions of this study included
the dependent variable of kill rates in Candida albicans isolates and eight levels of the

58
independent variable of treatment. These eight levels included treatment with the
individual essential oils lemongrass, oregano, and thyme, individual treatment of the
antifungal medications fluconazole and caspofungin, the combined treatment of the three
essential oils, the combined treatment of the three essential oils with fluconazole, and the
combined treatment of the three essential oils with caspofungin. The sixth research
question had a dependent variable of inhibition of germ tube production with the
independent variable of treatment with three levels. These three levels of treatment were
the three combined essential oils, fluconazole, and caspofungin. The ability to measure
these treatment outcomes also allowed me to ascertain whether there was a causal effect
of the various treatments studied. The last research question had independent variables of
age, gender, race, and comorbidities and the dependent variable of Candida albicans
bloodstream infection.
Methodology

Population
The population for this study were adult patients (18-74 years of age) at a large
teaching hospital who have had at least one positive blood culture with Candida albicans
recovered within the past 7 years. Isolates recovered from blood cultures were cryopreserved at -80º centigrade. Isolates were stored from the previous 7 years, and patient
demographics were also available for this timeframe. Blood cultures with multiple
organisms isolated were not included, and only the information from the initial isolate of
Candida albicans from a patient’s hospital stay was collected. Patients who had Candida
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albicans isolated from a blood culture were included regardless of the length of stay.
This population consisted of patients of various age, gender, race, and comorbidities.
Sampling and Sampling Procedures
The sampling techniques can be either a nonprobability method, which have a low
generalizability, or a probability method, which can be generalized to the population with
a higher degree (Burkholder, n.d.). In this study, the method used could be considered to
have a low generalizability to the population at large but a high generalizability to the
population receiving antifungal medications for Candida infections (Crosby,
DiClemente, & Salazar, 2013). Using a sample strategy that can be generalized to the
population at large would not be feasible due to the purpose of studying isolates
recovered from bloodstream infections that may be immunocompromised patients, while
the general population will include people who are immunocompetent and are less likely
to have Candida albicans bloodstream infections. However, further studies could
provide additional information outside of the hospitalized, potentially
immunocompromised population.
A stratified sample was also used in this research to divide the sample frame into
subpopulations. Variables for stratification include age, gender, and race (Crosby et al.,
2013). For this study, the sampling population was all-aged adults, gender, race, and
comorbidities seen at this large teaching hospital. The hospital internal review board
(IRB) approved data collection for patient covariates to be obtained using access to the
electronic health records (EHR) of patients who have previously been identified as
having a Candida albicans bloodstream infection through a log sheet stored in the
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microbiology department. The data were logged into a spread sheet with only age group,
race, gender, and comorbidities. In defining comorbidities for epidemiologic studies,
Yang et al. (2014) cited organ tumors, hematologic malignancy, diabetes, chronic
pulmonary disease, renal failure, and cardiac disease as the primary comorbidities. Hu et
al. (2014) reported that the main comorbidities included diabetes, solid tumor cancer,
hematologic malignancy, cardiac, renal, or hepatic failures, as well as
immunosuppression. Shigemura et al. (2014) listed diabetes, cancer, cardiovascular,
renal, and liver diseases as the main comorbidities in reporting on 110 cases of Candida
bloodstream infections. Although Kaye et al. (2011) also noted diabetes, metastatic
malignancy, and chronic pulmonary or heart disease, HIV was also listed as a
comorbidity in the 830 cases of blood stream infections from any type of organism.
Based upon the reviewed epidemiologic reports, and the variety of patients who were
seen at the hospital where the data were collected, the comorbidities that were evaluated
included diabetes, kidney failure, organ transplant, stem cell transplant, solid organ tumor
cancer, positive HIV status, hematological malignancy, substance abuse, abdominal
surgery, severe burns, other types of surgery, soft tissue cancer, autoimmune disorder,
and multiple organ failures. To compare covariates of a noninfected control group to the
covariates of patients with Candida albicans blood stream infections, an aggregated
sample of patient demographics and comorbidities were collected for the same period,
and a randomized sample of 120 patients were pulled from the EHR using a research
randomizer program (Research Randomizer, n.d.). There were no patient identifiers
stored in the data spreadsheet for this research. To begin the process to de-identify
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patients, the age groups were divided as 18-24, 25-34, 35-44, 45-54, 55-59, 60-64, and
65-74. Age groups were separated into divisions used by the United States Census
Bureau (n.d.) because investigating epidemiology of bloodstream infections has referred
to mean age, not age groups (Hu et al., 2014; Kaye et al., 2011; Shigemura et al., 2014;
Yang et al., 2014). The hospital required a full IRB approval for data collected on
patients 75 years and older therefore data were chosen to be collected on adults under the
age restriction (University of Colorado Health [UCH], n.d.). Sample size affects the
statistical significance (p value), and a larger sample size of 100 patients or more is
preferred. The sample size was dependent upon the number of isolates recovered and
frozen in the previous 9 years. Initial Candida albicans isolates were found by reviewing
the positive blood culture patient log stored in the microbiology department’s records.
These log forms had minimal patient demographics, and the additional covariate
information were accessed through the EPIC medical records system and documented
without patient names on a spreadsheet that lists organisms as arbitrary numbers. The
patient’s data were initially sorted by age due to the normal decrease of the immune
response of healthy, elderly patients (Wanke et al., 2000). The sample size was based
upon the number of isolates of Candida albicans recovered and saved from 2009 through
August 2017 that met the criteria including whether all the patient covariates were
available. Immunocompromised patients who received bone marrow transplants had an
11.4% risk of developing invasive Candida infections (Goodrich et al., 1991). A
G*Power analysis calculated that with a power (1-β) =1.0 and an α err of 0.05, the total
sample size would need to be 118 patients for an effect size of 0.25 (G*Power, n.d.).
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This was calculated using an ANOVA repeated measures, within between factors test
comparing eight groups and 10 measurements. This calculation was used to assess the
first six research questions. Using a G*Power analysis for logistic regression, the total
sample size for the patient demographics of 220, the power (1-β err prob) = 0.992.
Data Collection Procedure
The data collected from each patient listed age, gender, race, and comorbidities.
Data was also collected on the growth response of Candida albicans in the presence of
individual essential oils and the oils combined, and growth response of the organism to
the combined use of essential oils and antifungal medications. Data collected from
culture growth included the amount of growth at each time interval tested for each test
treatment at 24 and 48 hours of incubation, and whether each treatment inhibited the
germ tube production of each organism tested.
The patient data was de-identified and stored as isolate numbers only with gender,
race, age range, and co-morbidities listed on a password protected portable drive. This
information has been kept in a private office with limited access. The data will be
compiled and presented at Infectious Disease rounds and at an annual conference on
essential oil uses.
Instrumentation and Scale
To investigate the efficacy of treatment with essential oils in combination with
prescribed antifungal medications on the time to kill Candida albicans recovered from
hospitalized patients, an interval scale was used to determine the number of hours that the
Candida albicans isolates were exposed to the various treatments to obtain cell death and
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germ tube inhibition. An interval scale was used to measure the distance between
variables but cannot be used to determine a ratio (Kimberlin & Winterstein, 2008). The
interval scale for this study measured the time it took for the organism to be killed with
the essential oil treatment compared to standard treatment, and the combined treatment.
The level of measurement was chosen as a measure of the time until the organism was
dead. A ratio level was used to compare the kill rates of the antifungal treatment with the
essential oil treatment. A ratio scale was used to determine order, quantitate any
differences between the values, and to calculate ratios (Kimberlin & Winterstein, 2008).
Testing a patient for cure from a Candida infection, is done by culturing
specimens collected from the site of the patient’s infection and quantitating any growth of
Candida that occurs (Clinical Laboratory Standards Institute, n.d.). Essential oils have
been shown to reduce virulence factors in Candida and to kill yeast and fungus in
laboratory tests (Cleff et al., 2010). Essential oils have also been shown to increase the
effectiveness of antibiotics when used in conjunction in-vivo (Langeveld, Veldhuizen, &
Burt, 2013; Yap, Lim, Hu, & Yiap, 2013). These published research results would
indicate that the test methods for this study were appropriate to measure whether essential
oil are effective when used in addition to treatment protocols in laboratory testing of
Candida albicans isolates.
To verify whether Candida grew or not after the treatment protocols in the
different test variables, a colony count method using a modified Serum Inhibitory Test
was used to quantitate how many colonies of the Candida albicans grew in culture when
exposed to either the essential oil or the antifungal medication as well as the combined
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treatment. Serum Inhibitory Titers have been used since the 1950’s and provide a
standardized method for verifying treatment with antimicrobials (Woolfrey et al., 1986).
This method was used as a scale to evaluate the culturing techniques and the growth
abilities of the organism after treatment exposures. The data points were plotted and
compared to each test parameter and by the covariates to examine whether any other
variables such as age, gender, race, or comorbidity affected the outcomes or risk of
infection.
Exposure to treatments for kill times were based upon 1 hour, 4 hours, 8 hours, 12
hours, and 24-hour incubation. Each Candida isolate was brought to a 0.5 McFarland
standard, or approximately 1.5 × 108 colony forming units per milliliter (cfu/ml), using a
5ml tryptic soy broth (TSB), acquired from Hardy Diagnostics. This was followed by the
addition of the treatment level. The first protocol was done using each organism
suspension in TSB inoculated with 10 µl of lemongrass essential oil and incubated at
35ºC for the time intervals. At each time interval, 10 µl of the inoculated TSB was plated
onto Hardy Diagnostics Sabouraud Dextrose (SabDex) agar. The Sabdex plate was then
incubated at 35ºC and examined for growth at 24 and 48 hours. The total colony count
on each agar plate was recorded at the 24 and 48-hour time frames. The absence of
Candida growth on the agar plate after 48 hours was considered organism death. This
protocol was replicated each time with fresh organism suspensions and 10 µl of oregano
essential oil; then a new suspension and 10 µl thyme; a new suspension of organism and
10 µl of an evenly combined mixture of lemongrass, oregano, and thyme (LTO) essential
oils (10 µl of a mixture of 60 µl each of the three oils). This was then followed by fresh
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organism suspension in TSB along with a standardized 25 µg disk of fluconazole and a
fresh organism suspension with standardized 5 µg of caspofungin. Then fresh organism
suspension with 10 µl of LTO plus the 25µg disk of fluconazole and lastly a fresh
organism suspension with 10 µl of LTO plus 5 µg of caspofungin.
Disruption of the virulence factor of germ tube production was performed by
inoculating a germ tube production media with each yeast isolate, incubating for 1-2
hours and then microscopically examining for germ tube production. This test was
performed with just the media and the isolate to confirm that the organism produces germ
tubes and then new germ tube media and each isolate with 5 µl of the LTO. This was
followed by new germ tube media, the isolate, and 25 µg fluconazole disk as well as new
germ tube media, the isolate, and 5 µg of caspofungin.
Establishing Reliability for the Measurement and Scale
Reliability of a test relates to whether the test can be replicated with similar
results (Kimberlin & Winterstein, 2008). In this study, the ability to test and re-test for
the same outcome on an individual isolate would be feasible due to being able to
maintain Candida isolates for an extended length of time. Another option for reliability
would be to repeat the same study with an additional group of isolates from a different
facility; from a different time-frame; or from a different specimen source. Since all the
isolates came from bloodstream infections, replicating the specimen source and culturing
all the samples in the same way and incubating them for the same length of time provided
an additional level of reliability to the test. To ensure thorough replication, the test
methods were performed in the same way for each treatment session. The potential
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causal effect of adding essential oils for treatment was verified by evaluating whether the
isolates that received essential oils and antifungal medications were killed in less time or
more often than when these isolates only were exposed to the antifungal medications.
Establishing Validity
For a measure to have content validity it should measure the variable that it was
intended to measure (Kimberlin & Winterstein, 2008). Content validity is used to
examine whether the test measures all the items the test should measure in relationship to
the construct (Gabrenya Jr., 2003). The measurement of Candida growth in culture was
verified using the Clinical Laboratory Standards Institute’s (CLSI’s) guidelines (2015)
for standardized culturing of Candida species. The specimens collected for this study
were all from a blood culture source. The face validity should be high for this study
because the measurements for culture growth have been previously established as a test
for kill rates and minimum inhibitory concentrations (CLSI, n.d.). The measurements
were used to assess the construct that antifungal medications can be used to treat Candida
infections and to assess whether the essential oils treatments provided the same or
improved benefit (CDC: MASTER, n.d.). The content validity for sampling is used to
estimate how much the measure represents the actual elements in the construct (Gabrenya
Jr., 2003). The variables in this study were measured individually and well-established
culture and sampling techniques were used to test for kill rates therefore, the sampling
content validity was assumed to be strong.
The statistical evidence that a diagnostic instrument measures what it is supposed
to measure is known as the empirical validity (Gabrenya Jr., 2003). The preliminary lack
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of growth on culture media for Candida albicans would indicate that the treatment
method is inhibiting the organism and not actually killing the organism. To ensure the
validity of culture method, the specimens were plated on agar plates that enhance yeast
growth and then incubated for 48 hours. The 10µl of treated broths were also inoculated
into a new TSB tube to help facilitate inhibited organisms or low quantities of organisms
into growing. This enrichment broth served as a vehicle to promote growth for
organisms that may be weakened due to a treatment that is merely fungistatic and not
fungicidal. These broth cultures were held for seven days to encourage the growth of
weakened but still living yeast. After the seven days, 10 µl of the broths were inoculated
onto SabDex agar then incubated for 48 hours and any colony growth was recorded.
Construct validity relates to the overarching quality of the research, the ability for
the model to fit the data, and the ability to correlate results using the instrument
(Alumran, Hou, Sun, Yousef, & Hurst, 2014). The observed results of how things work
correlate with the theoretical pattern of how things work (Kimberlin & Winterstein,
2008). Antifungal medications work against yeast and fungus in similar ways that
antibiotics work against bacteria (CDC, n.d.1). These medicines work in various ways
including inhibiting replication of the organism or damaging the cell wall of the organism
so that the immune system can work more effectively against the organism (CDC:
MASTER, n.d.). However, immunocompromised patients lack the ability of the immune
system to interact with antimicrobials effectively due to the compromised state of the
immune system (Pellegrino et al., n.d.). To generalize this concept, it could be assumed
that if the use of essential oils worked well to rid an immunocompromised patient of a
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yeast infection, then it would work as well in people that have an intact immune system.
Utilizing a standardized test method for the growth of the organism in conjunction with
comparing both types of treatment as well as the combined treatment also increased the
construct validity of this research.
The strengths for measuring growth of Candida albicans from patients with
known infections are increased by using standardized methods for culture techniques that
are used in microbiology laboratories around the world (CLSI, n.d.). These methods
have been well documented and confirmed as the best methods that are available. The
measurement of growth or no growth of Candida has been shown to be a valid and
representative method for detecting Candida resistance to treatment regimens (CLSI,
n.d.).
Addressing Potential Weaknesses and Threats to Validity
Potential weaknesses could be a misidentification of an organism that was
previously identified as Candida albicans but was actually the phenotypically similar
Candida dublinensis. To reduce the risk of reporting results on the wrong organism, the
isolate identifications were confirmed with a matrix assisted laser desorption/ionizationtime of flight (Maldi-TOF). Accurately measuring incubation time and growth results for
each culture were tracked using a spread sheet to keep track of the time set up and time
for each read. Threats to external validity were minimized due to the ability to accurately
measure culture growth for the organisms. Rigor can be assured for validity of the study
due to standardized culture testing using the same collection devices, the same media,
and incubating the cultures for the same overall length of time.
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Analysis
The study to determine the effectiveness of essential oil against Candida albicans
infections is considered an experimental test due to the attempt to correlate the cause and
effect relationship of adding essential oils to the standard treatment and whether this
improves the curing of Candida infections. The testing of each isolate against both the
antifungal treatments and the essential oil treatments to determine whether the Candida
has survived treatment during the study is a norm-referenced test (NRT) because each
culture was compared to the others in each individual test group as well as across the
control and test groups ("Criterion and Standards Referenced Tests," 2007). This type of
comparison also allowed for the results to be compared by groups based on age, gender,
race, and comorbidities. The statistical software SPSS was used to perform statistical
analyses.
The initial research hypothesis examined lemongrass essential oil compared to the
antifungal medications, caspofungin and fluconazole on Candida albicans kill rates. The
second research hypothesis examined oregano essential oil compared to caspofungin and
fluconazole on Candida albicans kill rates. The third research hypothesis examined
thyme essential oil compared to caspofungin and fluconazole on Candida albicans kill
rates. It was hypothesized that the use of the essential oils would have a significant
difference in kill rates compared to the standard antifungal medications. The fourth
hypothesis was used to evaluate the combined lemongrass, oregano, and thyme essential
oils compared to standard antifungal medications. It was hypothesized that the combined
use of essential oils would have a significant difference in kill rate compared to
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caspofungin and fluconazole. A two-way repeated measures ANOVA was used to
evaluate what impact the individual oils had on the organism in culture when compared
to only exposing the culture to antifungal medications. This was used to assess what
impact each oil had on the treatment, what impact the combined use of the oils had on the
treatment efficacy, how the main effects interacted, and what effect these interactions had
on the Candida infection. The fifth hypothesis was used to investigate the combined use
of lemongrass, oregano, and thyme essential oils in conjunction with caspofungin and
fluconazole. It was hypothesized that there would be a significant difference in kill rates
compared to the use of antifungal alone. Again, a two-way repeated measures ANOVA
was used to compare the groups. The sixth research hypothesis was used to test how the
combined use of lemongrass, oregano, and thyme essential oils compared to caspofungin
and fluconazole to inhibit germ tube production. It was hypothesized that there would be
a significant difference between the combined essential oils and the antifungal
medications on germ tube production. This comparison was evaluated using a paired
samples t-test. The final research hypothesis was used to assess the covariates of age,
gender, race, and comorbidities as risk factors for Candida albicans bloodstream
infections. A univariate analysis was used to determine the frequency of how many
people in the study population belong to which age group then a binomial logistic
regression and multinomial logistic regression were used to study the relationship
between covariates and infections (Burkholder, n.d.).
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Ethical Concerns
The hospital where the isolates were collected provided a template for informed
consent that was submitted to the hospital’s IRB prior to research approval. This
template as well as the IRB assured that the patients’ identities would be protected, the
patients would not be discriminated against, and that the patients or their families would
not be contacted in relation to this study (University of Colorado Health [UCH], n.d.).
The data collected was entered into a UCH IRB approved computerized spreadsheet with
the de-identified information stored on a password protected computer that is only
accessible by myself and maintained in a secure area with limited access. The data has
been maintained for the duration of the research and no patient identifiers were associated
with the data. To reduce potential bias from the investigator on the efficacy of treatment,
the specimens were blinded using a coded sheet and the de-identified patient
demographics were not available while performing the experimental portion of the study.
Summary
Using a rigorous experimental study will enable healthcare providers to evaluate
the research and determine whether this treatment addition is effective enough to be used
for further research using volunteers as well as put into future recommendations as an
improvement in best practices. This research was developed using an experimental
design and evaluating the risk for Candida albicans bloodstream infections based on
gender, race, age group, and co-morbidities. The effectiveness of treatment options was
evaluated in attempts to expand into future research for improving clinical outcomes and
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reducing expenses related to long-term treatment of critically ill patients with Candida
infections.
This chapter outlined the selection of an experimental study design and the
rationale to investigate risks associated with gender, race, age, and co-morbidities. The
study variables, data access, and data collection were also addressed. Results from this
study will be compiled in Chapter 4 and discussed in Chapter 5
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Chapter 4: Results
Introduction
The purpose of this study was to evaluate the effect of lemongrass, oregano, and
thyme essential oils on Candida albicans’ ability to grow in the presence of each
individual oil and the three oils combined in comparison to the antifungal treatments of
fluconazole and caspofungin. In addition, Candida albicans’ ability to produce germ
tube virulence factors when exposed to the combined essential oils, caspofungin, and
fluconazole was compared to the ability to produce germ tubes without any treatment.
The gender, race, age group, and comorbidities of patients with Candida albicans
bloodstream infections were also examined for potential risk factors in comparison to a
control group that had blood cultures drawn during the same time-period but were
negative for Candida albicans bloodstream infections. An experimental method was
used to create and evaluate data for the first six research questions. A retrospective
quantitative method was used to analyze secondary data collected from medical records
of patients who had been hospitalized between January 2009 through August 1, 2017.
Statistical analyses were performed to address the research questions on study variables
and coding that were created during this study.
In this chapter, I describe the results from the following analyses: two-way
repeated measures ANOVA to measure the dependent variable of Candida albicans kill
rates over time when exposed to each study variable in the first five research questions;
descriptive statistics for virulence factors and patient demographics; binomial logistic
regression to examine patient demographics for risk factors; and multiple logistic

74
regression for potential confounders, such as age, gender, race, and comorbidities
including kidney failure, organ tumor cancer, and multiple organ failures.
Chapter 4 is organized into four sections. In the first section, I describe the data
collection, discrepancies from the initial plan in Chapter 3, the demographic and
descriptive analyses of the data collected, external validity, and the results of the
univariate analysis to justify the inclusion of the covariates in the evaluation of patient
demographics. In the next section, I show the treatment methods, problems encountered,
and how these problems were addressed. In the third section, I reported the analyses of
the statistical testing that was performed, assumptions that were addressed, as well as the
additional analysis used to address the examination of multiple comorbidities. I then
summarize the information presented in this chapter and leads into the transition to
discuss the results from the analyses in Chapter 5.
Data Collection
Descriptive statistical analyses were used to draw conclusions from the samples
tested. SPSS Version 24 was used to code and examine frequencies of data, relationships
between variables, and odds ratios for potential risk factors. Two-way repeated measures
ANOVA, descriptive statistics, and binomial and multiple logistic regressions were used
to evaluate the seven research questions and related hypotheses.
1.

RQ1: How does the use of lemongrass essential oil compare to standard
antifungal medications for Candida albicans kill rates in laboratory testing?
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H01: There is no significant difference in kill rates for the use of
lemongrass essential oil compared to standard antifungal medications for Candida
albicans in laboratory testing.
Ha1: There is a significant difference in kill rates for the use of lemongrass
essential oil compared to standard antifungal medications for Candida albicans in
laboratory testing.
•

Dependent variable: Candida albicans kill rates

•

Independent variable: treatment at set time intervals (lemongrass

exposure at 1,4,8,12, and 24 hours; caspofungin exposure at 1,4,8,12, and 24
hours; and fluconazole exposure at 1,4,8,12, and 24 hours).
2.

RQ2: How does the use of oregano essential oil compare to standard antifungal
medications for Candida albicans kill rates in laboratory testing?
H02: There is no significant difference in kill rates for the use of oregano
essential oil compared to standard antifungal medications for Candida albicans in
laboratory testing.
Ha2: There is a significant difference in kill rates for the use of oregano
essential oil compared to standard antifungal medications for Candida albicans in
laboratory testing.
•

Dependent variable: Candida albicans kill rates

•

Independent variable: treatment at set time intervals (oregano

exposure at 1,4,8,12, and 24 hours; caspofungin exposure at 1,4,8,12, and 24
hours; and fluconazole exposure at 1,4,8,12, and 24 hours).
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3.

RQ3: How does the use of thyme essential oil compare to standard antifungal
medications for Candida albicans kill rates in laboratory testing?
H03: There is no significant difference in kill rates for the use of thyme
essential oil compared to standard antifungal medications for Candida albicans in
laboratory testing.
Ha3: There is a significant difference in kill rates for the use of thyme
essential oil compared to standard antifungal medications for Candida albicans in
laboratory testing.
•

Dependent variable: Candida albicans kill rates

•

Independent variable: treatment at set time intervals (thyme

exposure at 1,4,8,12, and 24 hours; caspofungin exposure at 1,4,8,12, and 24
hours; and fluconazole exposure at 1,4,8,12, and 24 hours).
4.

RQ4: How does the combined use of lemongrass, oregano, and thyme essential
oils compare to standard antifungal medications for Candida albicans kill rates in
laboratory testing?
H04: There is no significant difference in kill rates for the combined use of
lemongrass, oregano, and thyme essential oils compared to standard antifungal
medications for Candida albicans in laboratory testing.
Ha4: There is a significant difference in kill rates for the combined use of
lemongrass, oregano, and thyme essential oils compared to standard antifungal
medications for Candida albicans in laboratory testing.
•

Dependent variable: Candida albicans kill rates
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•

Independent variable: treatment at set time intervals (combined

lemongrass, oregano, and thyme exposure at 1,4,8,12, and 24 hours; caspofungin
exposure at 1,4,8,12, and 24 hours; and fluconazole exposure at 1,4,8,12, and 24
hours).
5.

RQ5: How does the combined use of lemongrass, oregano, and thyme essential
oils when used with standard antifungal treatments compare to standard antifungal
medications for Candida albicans kill rates in laboratory testing?
H05: There is no significant difference in kill rates for the combined use of
lemongrass, oregano, and thyme essential oils when used with standard antifungal
medications compared to standard antifungal medications for Candida albicans in
laboratory testing.
Ha5: There is a significant difference in kill rates for the combined use of
lemongrass, oregano, and thyme essential oils when used with standard antifungal
medications compared to standard antifungal medications for Candida albicans in
laboratory testing.
•

Dependent variable: Candida albicans kill rates

•

Independent variable: treatment at set time intervals (combined

lemongrass, oregano, and thyme with caspofungin exposure at 1,4,8,12, and 24
hours, and combined lemongrass, oregano, and thyme with fluconazole exposure
at 1,4,8,12, and 24 hours).
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6.

RQ6: How does the combined use of lemongrass, oregano, and thyme essential
oils compare to standard antifungal medications for disruption of the virulence
factor of germ tube production of Candida albicans in laboratory testing?
H06: There is no significant difference in the combined use of lemongrass,
oregano, and thyme essential oils compared to standard antifungal medications for
disruption of the virulence factor of germ tube production of Candida albicans in
laboratory testing.
Ha6: There is a significant difference in the combined use of lemongrass,
oregano, and thyme essential oils compared to standard antifungal medications for
disruption of the virulence factor of germ tube production of Candida albicans in
laboratory testing.
•

Dependent variable: germ tube production

•

Independent variable: non-exposure; exposure to lemongrass,

oregano, and thyme; exposure to caspofungin; and exposure to fluconazole.
7.

RQ7: How do the covariates age, gender, race, or comorbidities contribute to the
risk of Candida albicans bloodstream infections?
H07: Age, gender, race, or comorbidities do not significantly contribute to
an increased risk of Candida albicans bloodstream infections.
Ha7: Age, gender, race, or comorbidities do significantly contribute to an
increased risk of Candida albicans blood stream infections.
•

Dependent variable: Candida albicans bloodstream infections

•

Independent variable: age, race, gender, and comorbidities
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Prior to analyzing the research questions, accuracy of coding the data in SPSS
was verified, and I confirmed that appropriate statistical assumptions were met.
Normality was determined and met for the variables in the first six research questions
using a Q-Q plot of studentized residual for time-treatment combinations. Mauchly’s test
for sphericity indicated that the assumption for sphericity had been violated for the twoway interaction between time and treatment so a correction for bias was made using a
Greenhouse-Geisser correction. Summary details of the variables and tests used to
evaluate the hypotheses are displayed in Table 1.
Table 1 Summary Details of Variables and Analyses used to Evaluate Hypotheses
Hypotheses

Independent Variable

Dependent Variable

1-5

Candida albicans kill rates

Treatment at time intervals

6

Germ tube production

LTO vs Caspofungin vs
Fluconazole

7

CABSI

Age, race, gender,
comorbidities

Analysis
Repeated
measures
ANOVA
Chi-square Test of
Independence
Binomial logistic
regression

Note. CABSI: Candida albicans bloodstream infections
LTO: Lemongrass, thyme, oregano essential oils combined

Descriptive Statistics
The initial criteria for selecting study participants were patients hospitalized
between January 2009 and August 1, 2017, in the age range of 18 through 74, who
acquired Candida albicans bloodstream infections during their length of stay at the
hospital. Once the number of patients during that time frame were gathered, the same
number of patients during the time period with blood cultures collected during a hospital
stay but negative for Candida albicans bloodstream infections were also collected. From

80
the 120 positive samples, the total number of Candida albicans isolates that were able to
be recovered from the frozen archives were 117. Although this was one less than the
G*Power analysis requirements of 118 for an effect size 0.25, using 117 still fit the
analysis for a power (1-β) =1.0 and an α err of 0.05. For the patients with Candida
albicans bloodstream infections during the collection time, a total of 107 patients were in
the age range of 18-74. Analysis of 113 randomized hospitalized patients with blood
cultures during the same period who did not have Candida albicans infections and were
in the selected age range was also performed. Using a G*Power analysis for logistic
regression with the total sample size for the patient demographics of 220, the power (1-β
err prob) = 0.992. Due to time and space constraints, the experiments to investigate the
first six research questions were divided into five groups. Initial tests were performed on
20 isolates with seven of the test levels (lemongrass, thyme, oregano, combined oils,
fluconazole, and combined oils with fluconazole). On this first day, time to kill rates
were collected at 1, 4, 8, 12 hours, and the following day at 24 hours. These inoculated
plates were incubated at 35°C, and colony counts were recorded at 24 hours and then
again at 48 hours to more accurately ensure organism death versus inhibition. On the
second day, an additional 20 isolates were tested with these initial incubation times
overlapping with the first set of isolates incubation period. With this many culture plates,
after the initial 24 hours of incubation and examination for colony growth, the 24-48-hour
culture plate incubation was performed at 25°C instead of 35°C. This lower incubation
does not impact the colony growth, only the size of the colonies. All colony counts were
examined using a lighted magnifying lens to ensure colonies were correctly counted.
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Incubation of all the isolates in TSB were performed at 35°C for the duration of the
experiment. Additional isolate groups were performed on subsequent weekends when
adequate space and time were available. Due to delivery difficulties of the antifungal,
caspofungin, all 117 isolates were tested against caspofungin and caspofungin with the
combined essential oils on the same weekend.
The test for the virulence factor of germ tube production was conducted during
these same time-frames. For the 117 isolates, 108 (92.3%) produced germ tubes in the
germ tube test medium alone; when the combined essential oils of lemongrass, thyme,
and oregano were added to germ tube test medium, 116 isolates did not produce germ
tubes and the germ tubes of the remaining isolate were abnormally large and deformed.
Adding caspofungin to the germ tube medium produced germ tubes in 110 of the isolates
(94.0%). The addition of fluconazole to the germ tube medium also resulted in 110 of the
isolates producing germ tubes. Adding caspofungin or fluconazole promoted germ tube
production in two additional isolates that did not produce germ tubes in the initial germ
tube medium only. These additional germ tube producing isolates were not the same
isolates for both fluconazole and caspofungin but rather four separate isolates. Seven
days following each set of experimental testing, each TSB broth was also sub-cultured
again to SabDex and examined for growth after 48 hours incubation at 35°C. None of the
isolates that had been exposed to any essential oil treatment in the TSB broth, including
those combined with the antifungals, were able to grow after 48 hours on the SabDex
medium. All the isolates that had been exposed to only caspofungin or fluconazole were
still viable for culture after seven days of exposure to the antifungals. When data
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collection was completed for the experimental portion of the study, patient demographics
were collected.
While collecting patient demographics, any comorbidity listed upon admission
was documented. After all the demographics were collected for the test and control
groups, a binomial logistic regression was performed to investigate the effects of age,
race, gender, and comorbidities on the likelihood of acquiring Candida albicans
bloodstream infections after admission. There were 15 individual comorbidities with
multiple patients having more than one comorbidity. The initial individual comorbidities
examined were diabetes, HIV/AIDS, kidney/renal failure, solid organ tumor cancer,
haemotologic malignancy, substance abuse, abdominal surgery, severe burns, organ
transplant, stem cell transplant, other surgeries, soft tissue cancer, autoimmune disorder,
multiple organ failure, and the rest were combined into an “other” category (see Table 2).
Table 2 Patient Data Collection
CABSI – Yes

CABSI – No

107

113

18-24

5 (4.7)

5 (4.4)

25-34

24 (22.4)

7 (6.2)

35-44

16 (14.9)

19 (16.8)

45-54

19 (17.8)

22 (19.5)

55-59

11 (10.3)

19 (16.8)

60-64

12 (11.2)

11 (9.7)

65-74

20 (18.7)

30 (26.6)

Male

58 (54.2)

69 (61.1)

Number of cases (n)
Age Group

Gender
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Table 2 continued

Race

Comorbidities

CABSI-Yes

CABSI-No

Female

49 (45.8)

44 (38.9)

White

69 (64.5)

62 (54.9)

Black

10 (9.3)

23 (20.4)

Hispanic

16 (15.0)

17 (15.0)

Other/Unknown

12 (11.2)

11 (9.7)

Diabetes

21 (19.6)

23 (20.4)

Kidney Failure

41 (38.3)

25 (22.1)

Solid Tumor Cancer

27 (25.2)

14 (12.4)

Haemotologic

1 (0.9)

3 (2.6)

Substance Abuse

8 (7.5)

8 (7.1)

Abdominal Surgery

11 (10.3)

5 (4.4)

Burns

4 (3.7)

2 (1.8)

Organ Transplant

14 (13.1)

13 (11.5)

HIV/AIDS

1 (0.9)

3 (2.6)

Stem Cell Transplant

0 (0)

2 (1.8)

Other Surgery

6 (5.6)

6 (5.3)

Soft Tissue Cancer

4 (3.7)

0 (0)

Autoimmune

5 (4.7)

0 (0)

9 (8.4)

25 (22.1)

Malig,

Disorder
Multi Organ Failure
Note: CABSI: Candida albicans bloodstream infection

While this model correctly classified 75% of the cases and explained 43%
(Nagelkerke R2) of the variance in Candida albicans bloodstream infections, the effect of
individual comorbidities as potential confounders was unclear. Data for the
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comorbidities were then reclassified individually and a multinomial regression was
performed to assess potential confounders.
There were 49 females out of 107 patients in the test group (45.8%) with a
slightly lower amount of 44 females in the control group of 113 (38.9%). The most
CABSI were in the age group 25-34 and the highest number for the control subjects was
in the 65-74 age group (see Figure 3).

Percent by Age Group
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Figure 3. Percent of CABSI and non-CABSI by age group.
Race was categorized based upon hospital demographics of White, Black,
Hispanic, or other/unknown. The other category includes records where race/ethnicity
were entered as unknown and for other groups which were in small numbers where deidentification would be difficult. Most of the patients in the test and control groups seen
at the hospital during this collection period were listed as White. Positive for CABSI
group had 64.5% listed as White and the control group (non-CABSI) had 54.9% listed as
White (see Figure 4).
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Percent Race by Test Group
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Figure 4. Percent of CABSI and non-CABSI by race.
Categorizing comorbidities as individual variables and calculating a Chi-square
test for association for each comorbidity with CABSI showed that kidney failure, solid
organ tumor cancer, autoimmune disorder, and multiple organ failure all had a
statistically significant association with CABSI however, for the autoimmune disorder,
not all expected cell frequencies were greater than 5 and therefore not included in the
final analyses. A multiple logistic regression was then performed on the combined
control and test groups for the comorbidities of kidney failure, solid organ tumor cancer,
and multiple organ failure. Combining the control group with the test group to the
analysis provided additional data points to determine whether any of these factors could
be determined to be statistically significant potential risk factors.
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Analyses of Tests for Hypotheses
Hypotheses 1-5 were evaluated using two-way repeated measures ANOVA to
determine if any statistically significant differences existed between treatment types over
a 24-hour time-frame. Hypothesis 6 was evaluated using a Chi-square test for
independence and to examine hypothesis 7, a binomial logistic regression was utilized
followed by a multinomial logistic regression to investigate potential confounders.
Specifically, the dependent variable for hypotheses 1-5 was the kill rates for Candida
albicans when exposed to the independent variables of treatment. Hypothesis 6 had a
dependent variable of germ tube production and hypothesis 7 had a dependent variable of
Candida albicans bloodstream infection.
The independent variables for hypotheses 1-5 were treatment with lemongrass,
oregano, thyme, combined essential oils, caspofungin, fluconazole, caspofungin with the
combined essential oils, and fluconazole with the combined essential oils. The
independent variables for hypothesis 6 were no treatment, treatments with combined
essential oils, fluconazole, or caspofungin. The independent variables for hypothesis 7
included age, race, gender, and comorbidities. Initial comorbidities included 12 variables
with only three with statistically significant results.
Results of Hypothesis 1
H01: There is no significant difference in kill rates for the use of lemongrass
essential oil compared to standard antifungal medications for Candida albicans in
laboratory testing.

87
Ha1: There is a significant difference in kill rates for the use of lemongrass
essential oil compared to standard antifungal medications for Candida albicans in
laboratory testing.
Using SPSS 24, a two-way repeated measures ANOVA was conducted to
determine whether statistically significant differences existed between treatment with
lemongrass, caspofungin, and fluconazole over five time-measurements. Results of mean
colony counts after a 24-hour plate incubation, indicated that at each exposure interval,
there was a lower mean colony count for lemongrass compared to exposure to
caspofungin and fluconazole. After an 8-hour exposure to lemongrass, the colony count
mean dropped to 0, the caspofungin colony count continued to lower, but after an 8-hour
exposure to fluconazole, the mean colony count increased above the 4- hour exposure.
Twelve- hour exposure to lemongrass again resulted with a mean of 0 colonies, colony
counts for caspofungin rose slightly, and fluconazole mean colony counts decreased
again. At the end of 24-hour exposure times, colony counts for exposure to lemongrass
remained at 0, caspofungin rose slightly, and colony counts for exposure to fluconazole
increased substantially (see Figure 5).
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Figure 5. Mean colony count of lemongrass, caspofungin, and fluconazole at
24hr.
The agar plates for these colony counts were then re-incubated for another 24
hours. Results of mean colony counts after the 48-hour plate incubation, indicated that at
each exposure interval, there was a lower mean colony count for lemongrass compared to
exposure to caspofungin and fluconazole. For the 8-hour exposure to lemongrass, the
colony count mean stayed at zero. The caspofungin colony count was also lower, but the
8-hour exposure to fluconazole, agar plate at 48 hours incubations was above the 4-hour
exposure count similar to the results after 24 hours incubation. Twelve- hour exposure to
lemongrass again resulted with a mean of 0 colonies, colony counts for caspofungin rose
slightly, and fluconazole mean colony counts decreased again. At the end of 24-hour
exposure times, colony counts for exposure to lemongrass remained at 0, caspofungin
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rose slightly, and colony counts for exposure to fluconazole increased substantially (see
Figure 6).
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Figure 6. Mean colony count of lemongrass, caspofungin, and fluconazole at 48hr.

Mean colony count results for 1-hour, 4-hour, 8-hour, 12-hour, and 24-hour
exposure to lemongrass, caspofungin, and fluconazole at 24-hour plate incubation and
48-hour plate incubation are listed in Table 3.
Table 3 Mean Colony Count After Exposure to Lemongrass, Caspofungin, and Fluconazole
Treatment
Exposure
Time

1 hour
4 hour
8 hour
12 hour
24 hour

Lemongrass

24hr plate
incubation
18.17
5.22
0
0
0

Caspofungin

48hr plate
incubation
28.48
8.54
0
0
0

24hr plate
incubation
36.66
19.13
9.21
9.71
11.60

Fluconazole

48hr plate
incubation
38.31
21.56
11.25
11.35
12.19

24hr plate
incubation
50.59
50.95
58.77
51.58
85.26

48hr plate
incubation
53.97
53.47
62.65
55.73
86.73

Results for lemongrass exposure after the increased plate incubation time showed
an increase in mean colony counts for the 1-hour and 4-hour exposure times. This
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increase in mean colony counts could indicate that at these lower exposure times the
organisms are being inhibited and are not completely killed. However, the 8-hour, 12hour, and 24-hour exposures to lemongrass maintained 0 mean colony counts which
would indicate that after sufficient exposure to lemongrass, the organisms are no longer
viable.
Caspofungin also had higher colony counts after 48-hours plate incubation,
verifying the antifungal inhibition properties. The mean colony counts for caspofungin at
24-hours and 48-hours plate incubation followed the same pattern of decreasing colony
count at 4-hours and 8-hours but beginning to increase again after 12 hours of exposure.
Caspofungin is considered to be fungicidal however, the organisms were not killed in the
time-frame of these experiments. Without additional antifungal being added, the
organisms were able to overcome the inhibition action of caspofungin and continue to
proliferate.
Fluconazole had higher mean colony counts at the 24-hour and 48-hour plate
incubations. Interestingly, the mean colony counts for Candida albicans with
fluconazole exposure decreased at the 4-hour and 12-hour exposure but not at the 8-hour
exposure and then had a substantial increase after 24 hours of exposure. The increase in
the mean colony counts at 8-hours of exposure were duplicated at the 24-hour and 48hour plate incubations. Clearly fluconazole is shown to begin to inhibit the organisms,
however this spike at 8 hours and jump at 24 hours may indicate that the medication may
not be able to sustain inhibition after 4 hours and drug dosing could become very
important with treatment options. Overall lemongrass had a lower mean colony count
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than both caspofungin or fluconazole for all exposure times at the 24-hour and 48-hour
plate incubations.
The mean kill rates of lemongrass essential oil were statistically significant over
time, F(1.617, 187.191)= 40.865, p<.0005. Test of within subject effect using a
Greenhouse-Geisser correction for the time and treatment interaction effect is .000
(p<.0005). There was a statistically significant interaction between lemongrass treatment
and time (see Table 4).
Table 4 Tests of With-In Subjects of Lemongrass Treatment Over Time
Source

df

F

Sig.

Lemongrass

1.617

40.865

<.001

Error (Lemongrass)

187.191

Over the time that Candida albicans isolates were exposed to lemongrass the
ability for the organisms to survive and proliferate decreased until at 8-hours of exposure,
the organisms were no longer viable. Using a pairwise comparison to measure
lemongrass exposure to caspofungin exposure, there was a colony count mean difference
of -12.582, 95% CI [-17.429 to -7.735], p<.0001 for lemongrass exposure compared to
caspofungin exposure. For the pairwise comparison of lemongrass exposure to
fluconazole exposure, the mean colony count difference was -54.50, 95% CI [-62.108 to 47.392], p<.0001 (see Table 5).
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Table 5 Pairwise Comparison Between Treatments
(I) to (J) treatment

Mean Difference (I-J)

Std. Error

Sig.

95% CI

Lemongrass to Caspofungin

-12.582

1.514

<.001

-17.429, 7.735

Lemongrass to Fluconazole

-54.750

2.299

<.001

-62.108, 47.392

Lemongrass exposure had a statistically significant lower mean colony count after
exposure when compared to caspofungin and fluconazole. Therefore, the null hypothesis
can be rejected in favor of the alternate hypothesis.
Results of Hypothesis 2
H02: There is no significant difference in kill rates for the use of oregano essential
oil compared to standard antifungal medications for Candida albicans in laboratory
testing.
Ha2: There is a significant difference in kill rates for the use of oregano essential
oil compared to standard antifungal medications for Candida albicans in laboratory
testing.
A two-way repeated measures ANOVA was conducted to determine whether
statistically significant differences existed between treatment with oregano, caspofungin,
and fluconazole over five time-measurements. Results indicated that at each time
exposure to oregano, there was a mean colony count of 0. Exposure to caspofungin and
fluconazole were discussed under Hypothesis 1 results. Results of mean colony counts
after a 24-hour plate incubation, indicated that at each exposure interval, there was an
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obvious lower mean colony count for oregano compared to exposure to caspofungin and
fluconazole (see Figure 7).
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Figure 7. Mean colony count of oregano, caspofungin, and fluconazole at 24hr.

The agar plates for these colony counts were then re-incubated for another 24
hours. The 48-hour growth for colony counts after 1-hour exposure to oregano increased
slightly to .05. All other time exposures with oregano had a mean colony count of 0
which was consistent with the 24-hour plate incubation. Caspofungin and fluconazole
exposures were previously discussed in Hypothesis 1 results. (see Figure 8).
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Figure 8. Mean colony count of oregano, caspofungin, and fluconazole at 48hr.

As indicated in Table 6, overall, oregano had a lower mean colony count than
both caspofungin or fluconazole for all exposure times at the 24-hour and 48-hour plate
incubations.
Table 6 Mean Colony Count After Exposure to Oregano, Caspofungin, and Fluconazole
Treatment
Exposure
Time

1 hour
4 hour
8 hour
12 hour
24 hour

Oregano

24hr plate
incubation
0
0
0
0
0

48hr plate
incubation
0
0
0
0
0

Caspofungin

24hr plate
incubation
36.66
19.13
9.21
9.71
11.60

48hr plate
incubation
38.31
21.56
11.25
11.35
12.19

Fluconazole

24hr plate
incubation
50.59
50.95
58.77
51.58
85.26

48hr plate
incubation
53.97
53.47
62.65
55.73
86.73

The mean kill rates of oregano essential oil were not statistically significant over
time, F(1, 116)= 1.813, p=.181. This is due to the lack of colony growth throughout the
exposure to oregano. While statistically this exposure over time for oregano is not
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significant, the fact that oregano killed off the Candida albicans isolates in such a short
exposure time provides an area to determine with future research whether this in-vitro
phenomenon would replicate in-vivo.
Using a pairwise comparison to measure oregano exposure to caspofungin
exposure, there was a colony count mean difference of –17.261, 95% CI [-21.499 to 13.023], p<.0001 for oregano exposure compared to caspofungin exposure. For the
pairwise comparison of oregano exposure to fluconazole exposure, the mean colony
count difference was -59.429, 95% CI [-67.025 to-51.832], p<.0001 (see table 7).
Table 7 Pairwise Comparison Between Treatments
(I) to (J) treatment
Mean Difference (I-J)

Std. Error

Sig.

95% CI

Oregano to Caspofungin

-17.261

1.324

<.001

-21.499, -13.023

Oregano to Fluconazole

-59.429

2.373

<.001

-67.025, -51.832

Oregano exposure had a statistically significant lower mean colony count after
exposure when compared to caspofungin and fluconazole. Therefore, the null hypothesis
can be rejected in favor of the alternate hypothesis.
Results of Hypothesis 3
H03: There is no significant difference in kill rates for the use of thyme essential
oil compared to standard antifungal medications for Candida albicans in laboratory
testing.
Ha3: There is a significant difference in kill rates for the use of thyme essential oil
compared to standard antifungal medications for Candida albicans in laboratory testing.
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A two-way repeated measures ANOVA was conducted to determine whether
statistically significant differences existed between treatment with thyme, caspofungin,
and fluconazole over five time-measurements. Mean colony count results for 1-hour, 4hour, 8-hour, 12-hour, and 24-hour exposure to thyme, caspofungin, and fluconazole at
24-hour plate incubation and 48-hour plate incubation are listed in Table 8. Results
indicated that at 8, 12 and 24-hour time exposure to thyme, there was a mean colony
count of 0. Exposure to caspofungin and fluconazole were discussed under Hypothesis 1
results. Results of mean colony counts after a 24-hour plate incubation, indicated that at
each exposure interval, there was a lower mean colony count for thyme compared to
exposure to caspofungin and fluconazole (see Figure 9).
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Figure 9. Mean colony count of thyme, caspofungin, and fluconazole at 24hr.

The agar plates for these colony counts were then re-incubated for another 24
hours. Results for thyme exposure after the increased plate incubation time showed a
slight increase in mean colony counts for the 1-hour and 4-hour exposure times. This
increase in mean colony counts could indicate that at these lower exposure times the

97
organisms are being inhibited and are not completely killed. However, the 8-hour, 12hour, and 24-hour exposures to thyme maintained 0 mean colony counts which would
indicate that after sufficient exposure to thyme, the organisms are no longer viable. (see
Figure 10).
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Figure 10. Mean colony count of thyme, caspofungin, and fluconazole at 48hr.

Overall, thyme also had a lower mean colony count than both caspofungin or
fluconazole for all exposure times at the 24-hour and 48-hour plate incubations.
Caspofungin and fluconazole mean colony counts were previously discussed under
Hypothesis 1 results. Thyme mean colony counts were below 1 colony forming unit after
the 48-hour plate incubation at the 4-hour exposure, this would indicate that similar to
oregano, further testing into in-vivo reactions could provide additional avenues for
research (see Table 8).
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Table 8 Mean Colony Count After Exposure to Thyme, Caspofungin, and Fluconazole
Treatment Thyme
Caspofungin
Fluconazole
Exposure
Time
24hr plate
48hr plate
24hr plate
48hr plate
24hr plate
incubation
incubation
incubation
incubation
incubation
1 hour
3.73
5.75
36.66
38.31
50.59
4 hour
0
0.40
19.13
21.56
50.95
8 hour
0
0
9.21
11.25
58.77
12 hour
0
0
9.71
11.35
51.58
24 hour
0
0
11.60
12.19
85.26

48hr plate
incubation
53.97
53.47
62.65
55.73
86.73

The mean kill rates of thyme essential oil were statistically significant over time,
F(1.108, 128.571)= 18.339, p<.0001. Test of within subject effect using a GreenhouseGeisser correction for the time and treatment interaction effect is .000 (p<.0005). There
was a statistically significant interaction between thyme treatment and time (see Table 9).
Table 9 Tests of With-In Subjects of Thyme Treatment Over time
Source

df

Error (Thyme)

128.571

Thyme

1.108

F

18.339

Sig.

<.001

Over the time that Candida albicans isolates were exposed to thyme the ability
for the organisms to survive and proliferate decreased until the organisms were no longer
viable. Using a pairwise comparison to measure thyme exposure to caspofungin
exposure, there was a colony count mean difference of –16.482, 95% CI [-20.631 to 12.333], p<.0001 for thyme exposure compared to caspofungin exposure. For the
pairwise comparison of thyme exposure to fluconazole exposure, the mean colony count
difference was -58.650, 95% CI [-66.286 to -51.014], p<.0001 (see Table 10).
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Table 10 Pairwise Comparison Between Treatments
(I) to (J) treatment
Thyme to Caspofungin
Thyme to Fluconazole

Mean Difference (I-J)
-16.482
-58.650

Std. Error
1.296
2.386

Sig.
<.001
<.001

95% CI
-20.631, -12.333
-66.286, -51.014

Thyme had a statistically significant lower mean colony count after exposure
when compared to caspofungin and fluconazole. Therefore, the null hypothesis can be
rejected in favor of the alternate hypothesis.
Results of Hypothesis 4
H04: There is no significant difference in kill rates for the combined use of
lemongrass, oregano, and thyme essential oils compared to standard antifungal
medications for Candida albicans in laboratory testing.
Ha4: There is a significant difference in kill rates for the combined use of
lemongrass, oregano, and thyme essential oils compared to standard antifungal
medications for Candida albicans in laboratory testing.
A two-way repeated measures ANOVA was conducted to determine whether
statistically significant differences existed between treatment of the combined use of
lemongrass, oregano, and thyme (LTO), with caspofungin, and fluconazole over five
time-measurements. Results indicated that at 1-hour, 4-hour, and 8-hour exposure to
LTO, there was colony growth. However, at the 12 and 24-hour exposure the mean
colony count for LTO was zero. Exposure to caspofungin and fluconazole were
previously discussed under Hypothesis 1 results (see Figure 11).
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Figure 11. Mean colony counts for lemongrass, oregano, and thyme (LTO), caspofungin,
and fluconazole at 24hr.

The agar plates for these colony counts were then re-incubated for another 24
hours. The 48-hour growth for colony counts after 1-hour, 4-hour, and 8-hour exposure
to LTO increased slightly. Caspofungin and fluconazole results after the 48-hour plate
incubation were previously discussed (see Figure 12).
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Figure 12. Mean colony counts for lemongrass, oregano, and thyme (LTO), caspofungin,
and fluconazole at 48hr.

Overall, LTO had a lower mean colony count than both caspofungin or
fluconazole for all exposure times at the 24-hour and 48-hour plate incubations.
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Combining the three essential oils seems to have a slightly antagonistic effect on
organism death seen with higher mean colony counts at 1-hour, 4-hour and 8-hour
exposure. However, at the 12-hour and 24-hour exposure times the effect appears equal
to testing each oil individually (see Table 11).
Table 11 Mean Colony Count After Exposure to LTO, Caspofungin, and Fluconazole
Treatment
Exposure
Time

LTO

Caspofungin

Fluconazole

1 hour

24hr plate
incubation
18.63

48hr plate
incubation
21.71

24hr plate
incubation
36.66

48hr plate
incubation
38.31

24hr plate
incubation
50.59

48hr plate
incubation
53.97

4 hour

1.83

3.87

19.13

21.56

50.95

53.47

8 hour

0.74

1.57

9.21

11.25

58.77

62.65

12 hour

0

0

9.71

11.35

51.58

55.73

24 hour

0

0

11.60

12.19

85.26

86.73

Note: LTO: Combined Lemongrass, Oregano, and Thyme

The mean kill rates of LTO combined essential oils were statistically significant
over time, F(1.609, 186.643)= 79.476, p<.0001 (see Table 12).
Table 12 Tests of With-In Subjects of LTO Treatment Over Time
Source

df

F

Sig.

LTO

1.609

79.476

<.001

Error (LTO)

186.643

Note: LTO: Combined Lemongrass, Oregano, and Thyme

Using a pairwise comparison to measure LTO exposure to caspofungin exposure,
there was a colony count mean difference of –12.995, 95% CI [-17.903 to -8.086],
p<.0001. For the pairwise comparison of LTO exposure to fluconazole exposure, the
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mean colony count difference was-55.163, 95% CI [-62.454 to -47.871], p<.0001 (see
Table 13).
Table 13 Pairwise Comparison Between Treatments
(I) to (J) treatment
LTO to Caspofungin

Mean difference (I-J)
-12.995

Std. Error
1.533

Sig.
<.001

95% CI
-17.903, -8.086

LTO to Fluconazole

-55.163

2.278

<.001

-62.454, -47.871

LTO had a statistically significant lower mean colony count after exposure when
compared to caspofungin and fluconazole. Therefore, the null hypothesis can be rejected
in favor of the alternate hypothesis.
Results of Hypothesis 5
H05: There is no significant difference in kill rates for the combined use of
lemongrass, oregano, and thyme essential oils when used with standard antifungal
medications compared to standard antifungal medications for Candida albicans in
laboratory testing.
Ha5: There is a significant difference in kill rates for the combined use of
lemongrass, oregano, and thyme essential oils when used with standard antifungal
medications compared to standard antifungal medications for Candida albicans in
laboratory testing.
A two-way repeated measures ANOVA was conducted to determine whether
statistically significant differences existed between treatment of the use of LTO
combined with caspofungin and the use of LTO combined with fluconazole, compared to
caspofungin, and fluconazole alone over five time-measurements. I found that at 1-hour
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exposure to LTO plus caspofungin (LTO+C) and LTO plus fluconazole (LTO+F), mean
colony counts were similar to each other but markedly lower than caspofungin or
fluconazole alone. Caspofungin and fluconazole mean colony counts were discussed
under Hypothesis 1 results at length. The results at 4 hours for both LTO+C exposure
LTO+F exposure dropped to mean colony counts below 1. After 8-hour exposure and
12- hour exposure to LTO+C, the mean colony counts stayed close to zero but at 24-hour
exposure, the mean colony count rose slightly to 0.51. At 8, 12, and 24-hour exposure to
LTO+F, mean colony counts dropped to zero (see Figure 13).
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Note: LTO+C: Lemongrass, Oregano, and Thyme combined with Caspofungin
LTO+F: Lemongrass, Oregano, and Thyme combined with Fluconazole

Figure 13. Mean colony counts of LTO+C, LTO+F, caspofungin, and fluconazole at 24
hr.

The agar plates for these colony counts were then re-incubated for another 24
hours. The 48-hour growth for colony counts after 1-hour exposure to LTO+C increased
slightly while the LTO+F mean colony count almost doubled. Slight increases after the
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48-hour plate incubation were seen at the 4-hour and 8-hour exposure for LTO+C, while
maintaining the same mean colony count at 12-hour exposure and raising slightly at 24hour exposure but still at less than 1 mean colony count. The LTO+F after the 48-hour
plate incubation had almost 2 colonies for the mean count but dropped to 0.5 at the 8hour exposure time and subsequent exposure hours of 12 and 24 maintained a 0 mean
colony count (see Figure 14).

Mean Colony Count at 48 Hour Plate Read
100
80
60
40
20
0
1 hour
LTO+C

4 hour
LTO+F

8 hour

12 hour

Caspofungin

24 hour

Fluconazole

Note: LTO+C: Lemongrass, Oregano, and Thyme combined with Caspofungin
LTO+F: Lemongrass, Oregano, and Thyme combined with Fluconazole

Figure 14. Mean colony counts of LTO+C, LTO+F, caspofungin, and fluconazole at
48hr.

Both combinations seemed to be more effective after the 1-hour exposure than
LTO alone or caspofungin or fluconazole alone. However, when isolates were exposed
to LTO combined with caspofungin there was a less than 1 mean colony count at 4-hours
of exposure and this was maintained at subsequent exposure times. A 0 mean colony
count was not achieved with LTO+C like it was at 12 and 24-hour exposure with LTO
alone (see Table 14).
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Table 14 Mean Colony Count After Exposure to LTO+C, LTO +F, Caspofungin, and Fluconazole
Treatment
Exposure
Time

LTO+C

LTO+F

Caspofungin

Fluconazole

24hr
48hr
24hr
48hr
24hr
48hr
24hr
P.I.
P.I.
P.I.
P.I.
P.I.
P.I.
P.I.
1 hour
6.03
7.51
8.18
16.10
36.66
38.31
50.59
4 hour
.07
.10
.53
1.96
19.13
21.56
50.95
8 hour
.04
.07
0
.05
9.21
11.25
58.77
12 hour
.05
.05
0
0
9.71
11.35
51.58
24 hour
.51
.54
0
0
11.60
12.19
85.26
Note: P.I.: Plate Incubation. LTO+C: Lemongrass, Oregano, Thyme and Caspofungin
LTO+F: Lemongrass, Oregano, Thyme and Fluconazole

48hr
P.I.
53.97
53.47
62.65
55.73
86.73

The mean kill rates of LTO+C were statistically significant over time, F(1.068,
123.887)= 33.079, p<.0001. For LTO+F the mean kill rates were statistically significant
over time, F (1.399, 160.871) = 68.639, p<.0001 (see Table 15). Indicating that in
laboratory testing, combining LTO with either caspofungin or fluconazole increased the
cellular death of Candida albicans isolates over exposure time.
Table 15 Tests of With-In Subjects of LTO+C and LTO+F Treatment Over Time
Source

Df

F

Sig,

LTO + Caspofungin

1.068

33.079

<.001

Error (LTO + Caspo)

123.887

LTO + Fluconazole

1.399

68.639

<.001

Error (LTO + Fluc)

160.871

Using a pairwise comparison to measure LTO+C exposure to caspofungin
exposure, there was a colony count mean difference of –15.913, 95% CI [-20.148 to 11.677], p<.0001. For the pairwise comparison of LTO+C exposure to fluconazole
exposure, the mean colony count difference was -58.080, 95% CI [-65.663 to -50.498],
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p<.0001. Using the pairwise comparison for LTO+F to caspofungin exposure, there was
a colony count mean difference of -15.502, 95% CI [-20.034 to -10.970], p<.001. For the
pairwise comparison of LTO+F to fluconazole exposure, there was a mean colony count
difference of -57.670, 95% CI [ -64.812 to -50.527], p<.001 (see Table 16).
Table 16 Pairwise Comparison Between Treatments
(I) to (J) treatment
Mean Difference (I-J)
Std. Error
LTO+C to Caspofungin
-15.913
1.323
LTO+C to Fluconazole
-58.080
2.369
LTO+F to Caspofungin
-15.502
1.416
LTO+F to Fluconazole
-57.670
2.231
Note: LTO+C: Lemongrass, Oregano, and Thyme + Caspofungin
LTO+F: Lemongrass, Oregano, and Thyme + Fluconazole

Sig.
<.001
<.001
<.001
<.001

95% CI
-20.148, -11.677
-65.663, -50.498
-20.034, -10.970
-64.812, -50.527

LTO+C and LTO+F both had a statistically significant lower mean colony count
after exposure when compared to caspofungin and fluconazole. Therefore, the null
hypothesis can be rejected in favor of the alternate hypothesis.
Results of Hypothesis 6
H06: There is no significant difference in the combined use of lemongrass,
oregano, and thyme essential oils compared to standard antifungal medications for
disruption of the virulence factor of germ tube production of Candida albicans in
laboratory testing.
Ha6: There is a significant difference in the combined use of lemongrass, oregano,
and thyme essential oils compared to standard antifungal medications for disruption of
the virulence factor of germ tube production of Candida albicans in laboratory testing.
To evaluate whether LTO exposure resulted in a significant decrease of germ tube
production when compared to caspofungin and fluconazole exposure, a paired samples t-
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test was used. The frequency of germ tube production with no exposures was 92.3% of
the isolates produced germ tubes. Indicating that 7.7% of the Candida albicans isolates
tested were not able to produce germ tubes in when exposed to media that enhances germ
tube production. When exposed to LTO only one isolate produced germ tubes that were
abnormally large and deformed this means that 99.1% of the isolates when exposed to
LTO were unable to produce germ tubes. When the isolates were exposed to
caspofungin, 94.0% of the isolates were still able to produce germ tubes. For exposure to
fluconazole, there were also still 94.0% of the isolates able to produce germ tubes. Germ
tube testing with each treatment mode was performed simultaneously with the organism
and only germ tube media as a control to ensure which organisms were able to produce
germ tubes. By performing the testing at the same time, ensured that the organism had
not lost the ability to produce germ tubes if the testing had been done with different
subcultures of isolates at different times. Including the control group also verified that
the organisms were still able to produce germ tubes since testing the caspofungin had to
occur at a later date than the LTO and fluconazole testing. The manufacturer also
indicates that there should be no more than six cells per 400x field to prevent false
negative results. Each testing vial was verified to not be over inoculated (data not
shown).
Comparing the ability for the organisms to naturally produce germ tubes in
specialized medium (GTM) with exposure to LTO in the specialized medium, a paired
samples t-test was performed to determine whether there was a significant difference first
between GTM and LTO with GTM. The t-statistic was significant at the 0.5 critical
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alpha level, t(116) =30.512, p<.0001. Comparing LTO exposure to caspofungin
exposure for germ tube production, the paired samples t-test indicated that the t-statistic
was significant at the 0.5 critical alpha level, t(116)= -33.495, p<.0001. Comparison of
LTO and fluconazole exposure was also performed using a paired samples t-test that was
significant at the 0.5 critical alpha level, with the same results of t(116) = -33.495,
p<.0001 (see Table 17). Therefore, the null hypothesis can be rejected, and the alternate
can be accepted.
Table 17 Comparison of Germ Tube Production Using Paired Samples t-Test
Paired Differences
GTM to LTO
LTO to Caspo
LTO to Fluc

t
30.512
-33.495
-33.495

df
116
116
116

Sig. (2-tailed)
.000
.000
.000

Mean
.906
-.923
-.923

95% CI (Lower, Upper)
.847, .965
-.978, -.868
-.978, -.868

Results of Hypothesis 7
H07: Age, gender, race, or comorbidities do not significantly contribute to an
increased risk of Candida albicans bloodstream infections.
Ha7: Age, gender, race, or comorbidities do significantly contribute to an
increased risk of Candida albicans blood stream infections.
To determine whether age, gender, race or comorbidities could be risk factors for
CABSI, a binomial logistic regression was performed to determine the probability of
being in the category of CABSI given the independent variables. Test for linearity was
not needed as all the independent variables are nominal and not continuous (Laerd
Statistics, 2015). The logistic regression model was statistically significant, χ2(28)
=86.304, p<.0001. The model explained 43% (Nagelkerke R2) of the variance in CABSI
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and correctly classified 75% of the cases. Sensitivity was 78%, specificity was 87%, the
positive predictive value was 75%, and the negative predictive value was also 75%. In
this model with all the comorbidities coded under one heading the only statistically
significant variable was the age group 25-34. To further investigate the factors associated
with the comorbidities, each comorbidity was separated into individual variables. A Chisquare goodness of fit test was performed to determine the highest level of prediction.
With age as a covariate, the model predicted 69.1% of the cases with a Pearson goodness
of fit of 115.295(106), p=.253. Using gender as a covariate, the model predicted 70% of
the cases correctly with a Pearson goodness of fit 112.424 (101), p=2.47.
Race as a covariate correctly predicted 69.5% of the cases with a Pearson
goodness of fit 112.418 (103), p=2.47. Utilizing comorbidities separately, kidney failure
as a covariate predicted 70% of the cases with Pearson goodness of fit at 112.24(101),
p=.206. Solid organ tumor cancer, autoimmune disorder, or multiple organ failure as
individual covariates all predicted the cases at the same level of 67.3% with a Pearson
goodness of fit of 42.305(13), p<.0001. Multiple combinations of covariates did not
improve the predictability of correct cases (data not shown).
Next a Chi-square test for association was done to determine which comorbidities
were significantly associated with CABSI. There was a statistically significant
association between CABSI and kidney failure, χ2(1) = 6.863, p=.009. Other statistically
significant associations with CABSI and a comorbidity included solid organ tumor, χ2 =
5.980 (1), p=.014, and multiple organ failure χ2 = 7.909 (1), p=.005. Autoimmune
disorder was also statistically significant but did not meet the criteria for each cell having
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greater than 5 cases for a Chi-square test for association and thus it was not included in
further analysis. To consider the overall effect of statistically significant nominal
variables, a likelihood ratio test was evaluated in SPSS. With no covariates, age, kidney
failure, solid organ tumor cancer, and multiple organ failure were all statistically
significant (see Table 18).
Table 18 Likelihood Ratio Test (No Covariates)
Effect

Chi-square

df

Sig.

Age

8.774

1

.003

Kidney Failure

9.584

1

.002

Solid Organ Tumor Cancer

7.835

1

.005

Multiple Organ Failure

7.237

1

.007

Using age as a covariate the variables kidney failure, solid organ tumor cancer,
and multiple organ failure were all still statistically significant (see Table 19).
Table 19 Likelihood Ratio Test (Covariate of Age)
Effect

Chi-square

df

Sig.

Kidney Failure

10.614

1

<.001

Solid Organ Tumor Cancer

8.904

1

.003

Multiple Organ Failure

8.068

1

.005

Age

18.795

6

.005

A binary logistic analysis was used next since the dependent variable has two
outcomes (yes or no). Using age as the only independent variable correctly predicted
56.4% of the CABSI cases with Exp (β)= .845, p=.022. Kidney failure as the only
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independent variable predicted 58.6% of the case with Exp(β) = 2.187, p=.009. Using
solid organ tumor cancer as the only independent variable predicted 57.3% of the cases
with Exp(β) = 2.387, p.016. Multiple organ as the only independent variable predicted
55.9% of the cases correctly with Exp(β) = .323, p=.007. Including all four of these
independent variables increased the correct predictability of the model to 69.1% which
was the highest percent for all possible combinations. With this model, age has an
Exp(β) = .762, p=.001. Kidney failure calculated as Exp(β) = 3.136, p=.006, solid organ
tumor cancer was similar with Exp (β) = 3.010, p=.006. Multiple organ failure had
Exp(β) = .306, p=.008. Further exploration using a multinomial logistic regression
produced similar results. For the risk of CABSI the age group of 24-35, kidney failure,
solid organ tumor cancer, and multiple organ failure were all still statistically significant
(see Table 20).
Table 20 Risk of CABSI Using Multinomial Logistic Regression
Exp (B)

Sig.

Age (25-34)

9.52

<.0001

Kidney Failure

.71

<.0001

Solid Organ Tumor Cancer

.71

<.003

Multiple Organ Failure

2.80

.005

It is important to note that for multiple organ failure, β= -1.129 which indicates
that there was a decrease in odds of having CABSI with multiple organ failure. This
model correctly predicted 69.5% of the cases which was slightly higher than the predicted
value using a binary analysis.
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Summary
Information discovered from this study may allow for practical measures to be
taken to disrupt the epidemiologic triangle and prevent Candida albicans bloodstream
infections in hospitalized patients. Essential oils such as lemongrass, oregano, and thyme
have shown to be statistically superior at killing Candida albicans in laboratory testing.
This information can be used in areas of cleaning as well as patient care. The reduction
of the virulence factor germ tube production when exposed to LTO provides areas to
improve patient outcomes with potential decrease in virulence of Candida albicans that
the patient may be exposed to in the environment. Data analysis of risk factors provide
areas to target protocols that could reduce patient risk for acquiring Candida albicans
bloodstream infections while in the hospital. In Chapter 4 I presented procedures used
for this data analyses as well as the analyses for the seven hypotheses for this study.
Of the seven hypotheses examined, all seven null hypotheses were rejected. A
significant difference in kill rates existed for each essential oil, the combined essential
oils LTO, as well as LTO plus caspofungin or fluconazole when compared to
caspofungin or fluconazole alone. LTO significantly reduced the germ tube production
of the Candida albicans isolates tested when compared to reduction of germ tube
production using caspofungin or fluconazole. Risk factors that were statistically
significant for Candida albicans bloodstream infections included age 25-34, kidney/renal
failure, solid organ tumor cancer, and multiple organ failure. While these risk factors
cannot be controlled, knowing that a patient has one or more of these risk factors could
allow for additional contact precautions, extra room cleaning, or astute attention to proper
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hand hygiene for each person entering these patient rooms. In Chapter 5 I will present
details of the interpretations of the findings of this study, the associated findings, as well
as strengths and limitations of the study. In addition, future recommendations for
research and social implications will be addressed.
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Chapter 5: Discussion, Conclusions, and Recommendations
Introduction
The purpose of this study was to investigate the impact of lemongrass, oregano,
and thyme essential oils individually and combined on Candida albicans ability to
reproduce in comparison to the antifungal medications, caspofungin and fluconazole
individually, and with the combined essential oils. Additional studies were performed to
determine whether the combined essential oils, caspofungin, or fluconazole inhibited the
virulence factor of germ tube production in Candida albicans isolates. The patient
demographics collected from patients with Candida albicans bloodstream infections were
compared to a control group of patients with blood cultures collected during the same
collection period without Candida albicans bloodstream infections to determine whether
age, race, gender, or comorbidities contributed to risk factors for these bloodstream
infections.
This study was quantitative in nature with experimental data collected for the first
six research questions and secondary data collected on patient demographics to evaluate
the seventh research question. Patients who acquire Candida bloodstream infections
during hospital stays have been shown in previous research to have a 30-day mortality
rate between 31 to 61% (Diekema, Arbefeville, Boyken, Kroeger, & Pfaller, 2012).
Calculating 30-day mortality rates for this study was beyond the scope of this research.
Future studies incorporating essential oils in different modalities and comparing mortality
rates of pre and post-incorporation would provide data on whether long-term
implementation of essential oils would be beneficial to patient outcomes. I found that
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lemongrass, oregano, thyme, and the oils blended together had statistically significant
higher kill rates on Candida albicans. isolates than caspofungin and fluconazole. In
addition, combining the blended oils with caspofungin or fluconazole also statistically
significantly improved the levels of kill rates compared to using caspofungin or
fluconazole alone. Germ tube virulence factors were also inhibited by the combined
treatment of lemongrass, oregano, and thyme. There was no statistically significant
inhibition of germ tube production with either caspofungin or fluconazole. Risk factors
that were statistically significant in contributing to Candida albicans infections included
the age group of 23-34 and the comorbidities of kidney failure, solid organ tumor cancer,
and multiple organ failures. These findings will be discussed in more detail in the
following section. I will also discuss limitations of the study, recommendations for future
research, and implications for social change.
Interpretation of the Findings
Lemongrass, thyme, and the three combined essential oils showed statistically
significant impact on the kill rates of the Candida albicans isolates tested over time.
Oregano did not have a statistically significant impact over time due to the high kill rates
after 1 hour. After allowing for a 48-hour growth period on culture plates to determine
whether the effect on the colonies were merely inhibition and not cell death, exposure to
lemongrass after 12 hours resulted in a mean colony growth of zero. The colonies were
no longer viable after being exposed to lemongrass for 12-hours. Oregano and thyme
both had a mean colony count of zero after only 4 hours of exposure of the isolates to the
respective essential oil. Combining the lemongrass, oregano, and thyme resulted in a
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similar result as lemongrass alone with the zero-growth rate of colonies after 12 hours.
The impact of lemongrass had previously been reported to have similar activity to
nystatin orally to treat oral yeast infections by Amornvit (2014). Although nystatin
cannot be used for invasive infections, lemongrass appeared in this study to have a higher
efficacy of yeast cellular death than either caspofungin or fluconazole which are used to
treat systemic fungal and yeast infections. Oregano and thyme in this study yielded
similar results that have previously been reported. Bellete et al. (2012) reported that low
concentrations of thyme essential oil were shown to be effective at inhibiting Candida
species. Omran and Esmailzadeh (2009) supported the evidence drawn from this study
that thyme has a higher level of inhibition than fluconazole; however, zones of inhibition
were used instead of verifying whether the organism is in fact killed when exposed to
thyme essential oil. I found that the organisms were killed when exposed to thyme and
not just inhibited. Pozzatti et al. (2008) indicated that Candida albicans isolates that
were resistant to fluconazole were highly susceptible to oregano essential oils. I found
that all Candida albicans isolates were highly susceptible to exposure to oregano after
only 1 hour. Although this study supported previous research that indicated the essential
oils lemongrass, oregano, and thyme were effective at inhibiting Candida albicans, it also
showed that the oils were effective at killing the isolates in less than 24-hours. Although
neither of the antifungals tested during this study were able to obtain a mean colony
count of zero, caspofungin had the lowest mean colony count of 8.76 after an 8-hour
exposure before an increase in mean colony counts at 12-hours. Fluconazole had the
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lowest of its colony counts at the 4-hour exposure time of 53.47 but then the colony
counts increased after further exposure.
After the initial inoculation of the essential oils or antifungals, no additional
treatments were added to the organisms growing in TSB. The essential oils continued to
kill the Candida albicans isolates, while the antifungals were able to inhibit temporarily,
but without additional treatments the organisms were able to overcome exposure and
continued to proliferate. Combining the essential oils and antifungals did not prevent the
essential oils from killing the isolates; however, the combination of LTO and fluconazole
had a mean rate of 0 which was slightly lower after 8 hours of exposure compared to
LTO and caspofungin, which had a mean colony count of 0.05 after 8 hours. The
addition of the combined essential oils did not inhibit the action of fluconazole or
caspofungin to the Candida albicans isolates, but rather provided an additional
mechanism to kill the organisms instead of merely inhibiting the growth of the
organisms. Although the use of the combined LTO did not completely kill after 1 hour of
exposure, it did still show statistically significant inhibition of the virulence factor of
germ tube production in laboratory testing.
Testing for germ tube production while simultaneously incubating isolates with
either LTO, caspofungin, or fluconazole also validated potential uses of lemongrass,
oregano, and thyme essential oils. The combined LTO essential oils inhibition of germ
tube production was statistically significant at the 0.05 critical alpha level. This
corresponds to previous research by Gaspar De Toledo et al. (2016) who indicated that
lemongrass inhibited hyphal formation as well as biofilm formation. Thyme was shown
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to inhibit virulence factors, such as proteinase, haemolysin, and biofilm production by
Khan, Ahmad, Cameotra, and Botha, (2014). Not only was germ tube production was
prevented, but biofilm development was diminished when used against Candida albicans
(Rodrigues, Rodrigues, Silva, & Henriques, 2017). Exposure to caspofungin and
fluconazole did not decrease germ tube production. Two isolates with exposure to
caspofungin and two different isolates exposed to fluconazole created germ tubes when
exposed to the antifungals but not when these four isolates were incubated only in the
germ tube medium. Fluconazole was unable to disrupt virulence factors in Candida
albicans (Khan et al., 2014). This phenomenon for lemongrass, oregano, and thyme to
disrupt virulence factors poses an interesting aspect for further research. Additional
research into potential risk factors rounded out this study of Candida albicans
bloodstream infections.
The potential risk factors for CABSI that were examined included, race, gender,
age, and comorbidities. Previous research by Yang et al. (2014) indicated that advanced
age and neutropenia were risk factors for Candida sepsis, however, for this research
group, the statistical significance for age as a risk factor was in a lower age group of 2534. In this study, gender and race were not statistically significant as had previously been
reported for all types of bloodstream infections by Kaye et al. (2011). A study by
Diekema et al. (2012) examining data from 1983 through 2007 reported that the mean
age in years ranged from 38 to 45.8 depending on the years of data collected for health
care associated Candida infections but the research did not list the age range of the data
collected over the 24- year time frame. This study by Diekema et al., (2012)
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unfortunately did not compare a control group to evaluate whether age was a risk factor.
It may also be relevant to note that the closer age-range from the Diekema et al., (2012)
study was from data collected in Iowa and the Yang et al., (2014) study was in Shanghai.
Additional nationwide research may shed light on whether age range is statistically
significant for risk factors of Candida albicans bloodstream infection and whether the
age range is consistently younger than reported in other countries. More in-depth
analysis of other factors for the 25-34 age group may provide additional insight for
preventative measures in the future. The relationship between the comorbidities of renal
failure, solid organ cancer, and multiple organ failure with CABSI were all statistically
significant; however, patients with multiple organ failure were at a decreased risk of
CABSI whereas renal failure and solid organ tumor cancer were positively related to
acquiring CABSI while hospitalized. Recognizing these potential risk factors can
provide areas to target for interventions to reduce the risk of Candida albicans
bloodstream infections. Data collected by Diekema et al., (2012) for 108 cases from
2004-2007 had surgery as the most patients with healthcare acquired Candida infections.
Again, without a comparison group, it is unknown whether this data reported by Diekema
et al., (2012) was statistically significant. In the study by Yang et al. (2014), neutropenia
was the most common comorbidity but there was no control group to compare for
statistical significance. While Kaye et al. (2011) indicated that obesity, surgery, and
previous hospital exposure were risk factors, the study only evaluated patients that were
in the age range of 69-79 and they examined all bloodstream infections, not just Candida
albicans. Sigemura et al. (2014) reported that 62% of patients with Candida bloodstream
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infections occurred in the Japanese study were under the age of 70 with cardiovascular
disease and surgery the more common comorbidities. Similar to the age group risk
factors, additional national research may indicate whether certain comorbidities are
significant risk factors for patients in the United States or perhaps in regions of the
United States.
Using the theoretical framework of the epidemiological triangle for this study
provided a foundation for potential areas of prevention and improving patient outcomes.
Recognizing potential risk factors such as age and comorbidities provides areas of
intervention including additional patient precautions for patients with these risk factors,
prudent hand washing by visitors and care providers, as well as studying the effects of
developing interventions such as diffusing the essential oils in patient rooms to
potentially disrupt the organism’s ability to survive in the host environment or topically
applying the essential oils to prevent colonization of Candida on skin surfaces. Further
studies in disrupting the epidemiological triangle would be warranted to verify these
areas as opportunities to prevent infections.
Limitations of the Study
Limitations to this study include the ability to apply this research to the general
population at large. This study examined the patient demographics and characteristics of
Candida albicans isolates from a large adult teaching hospital which may not apply to
smaller community hospital patients and the isolates recovered from these smaller
facilities. The adult age range of 18-74 may also limit the generalizability to the general
population outside of this age range as pediatrics and those over the age of 74 were not
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studied. Other potential limitations include the lack of further investigation into why the
age range of 25-34 was a risk factor. In addition, the ability to gather demographics and
isolates from other institutions was beyond the scope of this study. The experimental
data collected was from previously frozen isolates and this could have resulted in
organisms that were not as robust compared to the initial isolation of these organisms.
Controls and comparisons were built in to minimize this potential limitation.
Furthermore, how Candida albicans would react to the eight interventions while actively
infecting a patient was not determined. Any discrepancy between in-vitro and in-vivo
results due to host response to colonization versus invasive Candida albicans infections
could not be determined in this study. These limitations; however, also provide areas for
continued research.
Recommendations
The ability to provide a large sample size to study at a large teaching hospital
provided opportunities for future research. Areas for recommended further study include
whether diffusion of these essential oils in patient rooms could decrease the number of
Candida albicans infections as well as other Candida infections. In addition, further
investigations as to whether other Candida species such as Candida glabrata react in
similar manners when exposed to these essential oils compared to Candida albicans
could also prove to be beneficial. Candida albicans isolates had a disruption of germ
tube production when exposed to lemongrass, oregano, and thyme. Whether this is a
permanent disruption or whether the organism, if still viable, would be able to make germ
tubes when grown without the essential oils would require additional research. While
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there has been research involving the effect of lemongrass, oregano and thyme on
Candida isolates (Amornvit et al., 2014; Bellete et al., 2012; Boukhatem, Ferhat, Kameli,
Saidi, & Kebir, 2014; Nasir, Tafess, & Abate, 2015; Omran & Esmailzadeh, 2009;
Pozatti et al., 2008), the possibility of studying not only the effects of the oils on Candida
species, but also on how the patient responds to the oils being diffused or applied
topically remains to be determined again with future research. This study provided
additional information using a larger sample size as well as investigation into possible
combination therapy treatments. I will discuss further implications in the following
section.
Implications
Based on this research, further implications for positive social change include the
ability to improve the public’s health by limiting potential transmission of multi-drug
resistant yeast to others in the general population. This would be due to fewer Candida
isolates surviving long-term treatment with antifungal medications and therefore reducing
the likelihood of developing resistance to these drugs. With less multi-drug resistant
isolates developing, fewer of these isolates would be in circulation (CDC, 2011).
Information collected from this study could improve outcomes by targeting risk factors
for prevention and utilizing the essential oils from this research to disrupt the
epidemiological triangle and prevent infections from occurring while higher risk patients
are hospitalized. Reducing hospital acquired infections caused by Candida and other
organisms reduces the cost for the hospital and the patient (CDC, 2013). Decreasing
hospital acquired infections decreases the mortality rate due to these infections.
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Improved patient outcomes in clinics and hospital not only impacts the financial cost but
also the associated emotional and physical costs related to long-term illnesses on both the
family and patient,
The information collected from this study could provide a foundation for future
research involving other microbes and the effects of the interactions with essential oils to
reduce infection rates. Reduction of hospital acquired Candida infections could decrease
mortality rates and improve patient outcomes both while hospitalized and after discharge
by decreasing the likelihood of colonization and thus decreasing the potential risk of
infections of these patients. Reduction of these hospital acquired infections could also
decrease lengths of stay, decrease hospital charges to the patient, and decrease overall
hospital expenses.
Providing opportunities to change the environment of the patient’s room while
hospitalized would enable a reduction in the risk of infections while also giving patients
and their care givers the possibility to continue this mode of disruption for Candida
survival outside the hospital setting thus enabling self-care once the patient was
discharged. Additional research into potential modalities of treatment with essential oils
(aromatic, topical, or internal) in conjunction with standard medical treatment could open
additional areas for improving patient outcomes. Introduction of aromatic methods into a
hospital setting could be beneficial to the hospital as well as the patient. Targeting at-risk
patients to receive additional essential oil treatments whether it is simply diffusing
antifungal essential oils in the room during their stay or providing essential oils as
adjuncts to every room cleaning, reduction of hospital acquired infections could be
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monitored and the aromatic treatment modality could be validated as a new standard of
care. This in turn could lead to expansion into the additional treatment modalities in a
controlled research setting to monitor for improvement of patient outcomes. Improving
patient outcomes has a positive effect on the people, their families, and the communities
they live in. This can be achieved by decreasing patient length of stays in hospitals,
which in turn enables them to return to their communities, families, and way of life
sooner. This can also create ways to enable preventative care methods that prevent
additional hospitalizations, which then reduces financial burdens for the hospital, the
patient and those caring for them.
Conclusion
This study was used to examine a multitude of data that was created and collected
in the laboratory setting as well as investigating risk factors for CABSI at a large teaching
hospital with various patient demographics and comorbidities. Lemongrass, oregano,
thyme, and the three essential oils combined all showed statistically significant
improvement over caspofungin and fluconazole to not only inhibit Candida albicans
from growing but to also kill it within a brief time period. The ability for these oils to
rapidly kill Candida albicans not only decreases the likelihood of the development of
drug resistance but also minimizes the chance that the organism would contaminate the
environment and be spread to other areas and patients. Prevention of the germ tube
production virulence factor provides an exciting area for additional research on
preventing not only severe Candida albicans infections but less serious but troublesome
yeast infections as well. Targeting at-risk patients with prevention measures enables the

125
providers to concentrate on other aspects of admission without introducing an additional
life-threatening infection that needs to be aggressively and rapidly treated (CDC, 2011).
Further studies are needed to better understand the interactions of host cells, invading
organisms, and how essential oils interact in-vivo. While synthetic antimicrobial options
are very limited, and organisms have often developed resistance prior to the treatment
being approved for use on the public (CDC, 2011), essential oils provide a means to
potentially prevent infections and reduce resistance.
Anyone that has had a yeast infection regardless of the severity could potentially
benefit from this research for viable alternative treatment options. Hospitals and clinics
could benefit from this information by being able to reduce costs and improve patient
outcomes (Bliss et al., 2012). The ability to provide new ways for patients to engage in
treatment regimens helps to empower patients and their families by providing
opportunities to actively participate in the treatment plan which in turn can improve
outcomes and patient satisfaction. Research and inception of new treatment modalities
are rapidly needed in the United States to reduce mortality rates due to preventable
infections (CDC, 2011). The addition of essential oils into standard of care warrants
serious consideration and research such as this study continue to provide proof of validity
of these treatment potentials as well as means for implementation.

126
References
Agili, F. A. (2014). Chemical composition, antioxidant and antitumor activity of thymus
vulgaris L. essential oil. Middle-East Journal of Scientific Research, 21(10),
1670-1676. http://dx.doi.org/10.5829/idosi.mejsr.2014.21.10.85182
Alcazar-Fuoli, L., & Mellado, E. (2014). Current status of antifungal resistance and its
impact on clinical practice. British Journal of Haematology, 166, 471-484.
http://dx.doi.org/10.111/bjh.12896
Alumran, A., Hou, X., Sun, J., Yousef, A. A., & Hurst, C. (2014). Assessing the construct
validity and reliability of the Parental Perception on Antibiotics (PAPA) scales.
BioMed Central: Public Health, 14(79). Retrieved from
http://www.biomedcentral.com/content/pdf/1471-2458-14-73.pdf
Amornvit, P., Choonharuangdej, S., & Srithavaj, T. (2014). Lemongrass-incorporated
tissue conditioner against Candida albicans culture. Journal of Clinical and
Diagnostic Research, 8(7), ZC50-ZC52.
http://dx.doi.org/10.7860/JCDR/2014/8378.4607
Anderson, R., Tintinger, G., Cockeran, R., Potjo, M., & Feldman, C. (2010). Beneficial
and harmful interactions of antibiotics with microbial pathogens and the host
innate immune system. Pharmaceuticals, 3, 1694-1710.
http://dx.doi.org/10.3390/ph3051694
Bachmann, S. P., VandeWalle, K., Ramage, G., Patterson, T. F., Wickes, B. L., Graybill,
J. R., & Lopez-Ribot, J. L. (2002). In vitro activity of caspofungin against
Candida albicans biofilms. Antimicrobial Agents and Chemotherapy, 46(11),

127
3591–3596. http://dx.doi.org/10.1128/AAC.46.11.3591–3596.2002
Bellete, B., Raberin, H., Flori, P., Akssi, S. E., Manh Sung, R. T., Taourirte, M., & Hafid,
J. (2012). Antifungal effect of the essential oil of Thymus broussonetii Boiss
species of Morocco. Natural Product Research, 26(18), 1692-1696.
http://dx.doi.org/0.1080/14786419.2011.602019
Bliss, J. M., Wong, A. Y., Bhak, G., Laforce-Nesbitt, S. S., Taylor, S., Tan, S., ...
Benjamin, D. K. (2012). Candida virulence properties and adverse clinical
outcomes in neonatal candidiasis. Journal of Pediatrics, 161(3), 441-447.
http://dx.doi.org/10.1016/j.jpeds.2012.02.051
Boukhatem, M. N., Ferhat, M. A., Kameli, A., Saidi, F., & Kebir, H. T. (2014).
Lemongrass (Cymbogon citratus) essential oil as a potent anti-inflammatory and
antifungal drug. Libyan Journal of Medicine, 9.
http://dx.doi.org/10.3402/ljm.v9.24531
Brieger, K., Schiavone, S., Miller, F. J., & Krause, K. (2012). Reactive oxygen species:
From health to disease. Swiss Medical Weekly, 142.
http://dx.doi.org/10.4414/smw.2012.13659
Brown, G. D., Denning, D. W., Gow, N. A., Levine, S. M., Netea, M. G., & White, T. C.
(2012). Hidden killers: Human fungal infections. Science Translational Medicine,
4(165). http://dx.doi.org/10.1126/scitranslmed.3004404
Budzynska, A., Sadowska, B., Lipowczan, G., Maciag, A., Kalemba, D., & Rozalska, B.
(2013). Activity of selected essential oils against Candida spp. strains. Evaluation
of new aspects of their specific pharmacological properties, with special reference

128
to lemon balm. Advances in Microbiology, 3, 317-325.
http://dx.doi.org/10.4236/aim.2013.34045
Burkholder, G. (n.d.). Sample size analysis for quantitative studies. Retrieved April 8,
2015, from
https://class.waldenu.edu/bbcswebdav/institution/USW1/201550_27/XX_RSCH/
RSCH_8201/Week%206/Resources/Resources/embedded/Sample_Size_Analysis.
pdf
Calderone, R. A., & Fonzi, W. A. (2001). Virulence factors of Candida albicans. Trends
in Microbiology, 9(7), 327-335. http://dx.doi.org/10.1016/S0966-842X(01)020947
Centers for Disease Control and Prevention. (2011). CDC and fungal diseases: Why are
fungal diseases a public health issue? Retrieved March 14, 2015, from
http://www.cdc.gov/ncezid/dfwed/pdfs/fungal-factsheet-508c.pdf
Centers for Disease Control and Prevention. (2013). Antibiotic resistance threats in the
United States. Retrieved from http://www.cdc.gov/drugresistance/pdf/ar-threats2013-508.pdf
Centers for Disease Control and Prevention:.MASTER (n.d.). Retrieved from
http://www.cdc.gov/labtraining/master_courses.html
Centers for Disease Control and Prevention. (n.d.1). Concepts of disease occurrence.
Retrieved June 26, 2016, from
http://www.cdc.gov/ophss/csels/dsepd/ss1978/lesson1/section8.html
Centers for Disease Control and Prevention. (n.d.2). Invasive candidiasis statistics.

129
Retrieved July 1, 2017, from
http://www.cdc.gov/fungal/diseases/candidiasis/invasive/statistics.html
Cernicka, J., & Subik, J. (2006). Resistance mechanisms in fluconazole-resistant Candida
albicans isolates from vaginal candidiasis. International Journal of Antimicrobial
Agents, 27, 403-408. http://dx.doi.org/10.1016/j.ijantimicag.2005.12.005
Chander, J., Singla, N., Sidhu, S. K., & Gombar, S. (2013). Epidemiology of Candida
blood stream infections: Experience of a tertiary care centre in North India.
Journal of Infection in Developing Countries, 7(9), 670-675.
http://dx.doi.org/10.3855/jidc.2623
Cleff, M. B., Meinerz, A. R., Xavier, M., Schuch, L. F., Meireles, M. C., Rodrigues, M.
R., & Braga de Mello, J. R. (2010). In vitro activity of Origanum vulgare essential
oil against Candida species. Brazilian Journal of Microbiology, 41(1), 116-123.
http://dx.doi.org/ 10.1590/S1517-838220100001000018
Cleveland, A. A., Farley, M. M., Harrison, L. H., Stein, B., Hollick, R., Lockhart, S. R.
Chiller, T. M. (2012). Changes in incidence and antifungal drug resistance in
candidemia: Results from population-based laboratory surveillance in Atlanta and
Baltimore, 2008-2011. Clinical Infectious Diseases, 55(10), 1352-1361.
http://dx.doi.org/10.1093/cid/cis697
Clinical and Laboratory Standards Institute. (2015). M100-S25: Performance standards
for antimicrobial susceptibility testing. Wayne, PA: Author.
Clinical Laboratory Standards Institute website. (n.d.). Retrieved from
http://clsi.org/standards/

130
Crosby, R., DiClemente, R., & Salazar, L. (2013). Principles of sampling. In R. Crosby,
R. DiClemente, & L. Salazar (Eds.), Research methods in health promotion
(Custom ed., pp. 317-346). San Francisco, CA: Josey-Bass.
Custodio, J. B., Ribeiro, M. V., Silva, F. S., Machado, M., & Sousa, M. C. (2011). The
essential oils component p-cymene induces proton leak through Fo-ATP synthase
and uncoupling of mitochondrial respiration. Journal of Experimental
Pharmacology, 3, 69-76. http://dx.doi.org/10.2147/JEP.S16387
Diekema, D., Arbefeville, S., Boyken, L., Kroeger, J., & Pfaller, M. (2012). The
changing epidemiology of healthcare-associated candidemia over three decades.
Diagnostic Microbiology and Infectious Disease, 73, 45-48.
http://dx.doi.org/10.1016/j.diagmicrobio.2012.02.001
doTERRA CPTG Certified Pure Therapeutic Grade Quality Testing. (2016). Retrieved
from https://doterra.com/US/en/difference-quality-control-cptg
Ene, I. V., Adya, A. K., Wehmeier, S., Brand, A. C., MacCallum, D. M., Gow, N. A., &
Brown, A. J. (2012). Host carbon sources modulate cell wall architecture, drug
resistance, and virulence in a fungal pathogen. Cellular microbiology, 14(9),
1319-1335. http://dx.doi.org/10.1111/j.1462-5822.2012.01813.x
Enoch, D. A., Ludlam, H. A., & Brown, N. M. (2006). Invasive fungal infections: A
review of epidemiology and management options. Journal of Medical
Microbiology, 55, 809-818. http://dx.doi.org/10.1099/jmm.0.46548-0
Frankfort-Nachmias, C., & Nachmias, D. (2007). Research designs: Experiments. In
Research methods in the social sciences (7th ed., pp. 87-111). Duffield, United

131
Kingdom: Worth.
Frieden, T. R. (2011). CDC Health Disparities and Inequalities Report —United States,
2011. Morbidity and Mortality Weekly Report, 60(Supplement), 1-114. Retrieved
from http://www.cdc.gov/mmwr/pdf/other/su6001.pdf
G*Power website. (n.d.). Retrieved from http://www.gpower.hhu.de/
Gabrenya Jr., W. K. (2003). Validity. In Research skills for psychology majors:
Everything you need to know to get started (pp. 1-10). Retrieved from
http://my.fit.edu/~gabrenya/IntroMethods/eBook/validity.pdf
Gao, M., Singh, A., Macri, K., Reynolds, C., Singhai, V., Biswai, S., & Spannhake, E. W.
(2011). Antioxidant components of naturally-occurring oils exhibit marked antiinflammatory activity in epithelial cells of the human respiratory system.
Respiratory Research, 12(92). http://dx.doi.org/10.1186/1465-9921-12-92
Gaspar De Toledo, L., Dos Santos Ramos, M. A., Sposito, L., Castilho, E. M., Pavan, F.
R., De Oliveira Lopes, E., Gottardo De Almeida, M. T. (2016). Essential oil of
Cymbopogon Marcus (L.) rendle: A strategy to combat fungal infections caused
by Candida species. International Journal of Molecular
Sciences, 17(1252). http://dx.doi.org/10.3390/ijms17081252
Goodrich, J. M., Reed, E. C., Mori, M., Fisher, L. D., Skerrett, S., Dandliker, P. S., ...
Meyers, J. D. (1991). Clinical features and analysis of risk factors for invasive
Candidal infection after marrow transplantation. Journal of Infectious Disease,
164(4), 731-740. http://dx.doi.org/10.1093/infdis/164.4.731
Gupta, A., & Khanna, S. (2014). Community-acquired Clostridium difficile infection: An

132
increasing public health threat. Infection and Drug Resistance, 7, 63-72.
http://dx.doi.org/10.2147/IDR.S46780
Ha, K. C., & White, T. C. (1999). Effects of azole antifungal drugs on the transition from
yeast cells to hyphae in susceptible and resistant isolates of the pathogenic yeast
Candida albicans. Antimicrobial Agents and Chemotherapy, 43(4), 763-768.
Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC89204/
Hota, B. (2004). Contamination, disinfection, and cross-colonization: Are hospital
surfaces reservoirs for nosocomial infection? Clinical Infectious Diseases, 39(8),
1182-1189. http://dx.doi.org/10.1086/424667
Hu, B., Du, Z., Kang, Y., Zang, B., Cui, W., Qin, B., ... Li, J. (2014). Catheter-related
Candida bloodstream infection in intensive care unit patients: A subgroup analysis
of the China-SCAN study. BioMed Central Infectious Diseases, 14(594).
http://dx.doi.org/10.1186/s12879-014-0594-0
Jack, Jr., L., Hayes, S. C., Scharalda, J. G., Stetson, B., Jones-Jack, N. H., Valliere, M., ...
LeBlanc, C. (2010). Appraising quantitative research in health education:
Guidelines for public health educators. Health Promotion Practice, 11(2), 161165. http://dx.doi.org/10.1177/1524839909353023
Kalemba, D., & Kunicka, A. (2003). Antibacterial and antifungal properties of essential
oils. Current Medicinal Chemistry, 10(10), 813-829.
http://dx.doi.org/10.2174/0929867033457719
Kaye, K. S., Marchain, D., Chen, T., Chopra, T., Anderson, D. J., Choi, Y., ... Schmader,
K. E. (2011). Predictors of nosocomial bloodstream infections in older adults.

133
Journal of American Geriatrics Society, 59(4), 622-627.
http://dx.doi.org/10.1111/j.1532-5415.2010.03289.x
Khan, A., Ahmad, A., Akhtar, F., Yousef, S., Xess, I., Ahmad Khan, L., & Manzoor, N.
(2011). Induction of oxidative stress as a possible mechanism of the antifungal
action of three phenylpropanoids. Federation of European Microbiological
Societies: Yeast Research, 11(2011), 114-122. http://dx.doi.org/10.1111/j.15671364.2010.00697.x
Khan, M. S., Ahmad, I., Cameotra, S. S., & Botha, F. (2014). Sub-MICs of Carum
copticum and Thymus vulgaris influence virulence factors and biofilm formation
in Candida spp. BioMed Central Complementary and Alternative
Medicine, 14(337). http://dx.doi.org/10.1186/1472-6882-14-337
Kimberlin, C. L., & Winterstein, A. G. (2008). Validity and reliability of measurement
instruments used in research. American Journal of Health-System Pharmacists,
65, 2276-2284. Retrieved from
http://www.ajhepworth.yolasite.com/resources/9817Reliabillity%20and%20validity.pdf
Korenblum, E., De Vasconcelos Goulart, F. R., De Almeida Rodrigues, I., Abreu, F.,
Lins, U., Alves, P. B., ... Seldin, L. (2013). Antimicrobial action and anticorrosion effect against sulfate reducing bacteria by lemongrass (Cymbopogon
citratus) essential oil and its major component, the citral. AMB Express, 3(44).
http://dx.doi.org/ 10.1186/2191-0855-3-44
Kurtz, M. B., Abruzzo, G., Flattery, A., Bartizal, K., Marrinan, J. A., Li, W., ... Douglas,

134
C. M. (1996). Characterization of echinocandin-resistant mutants of Candida
albicans: Genetic, biochemical, and virulence studies. Infection and Immunity,
64(8), 3244-3251. Retrieved from http://iai.asm.org/content/64/8/3244.long
Laerd Statistics. (2015). Binomial Logistic Regression using SPSS Statistics. Retrieved
from https://statistics.laerd.com/premium/spss/blr/binomial-logistic-regression-inspss.php
Langeveld, W. T., Veldhuizen, E. J., & Burt, S. A. (2013). Synergy between essential oil
components and antibiotics: A review. Critical Reviews in Microbiology, 40(1),
76-94. http://dx.doi.org/10.3109/1040841X.2013.763219
Lewis, R. E., Viale, P., & Kontoyiannis, D. P. (2012). The potential impact of antifungal
drug resistance mechanisms on the host immune response to Candida. Virulence,
3(4), 386-376. http://dx.doi.org/10.4161/viru.20746
Leyva-Lopez, N., Nair, V., Bank, W. Y., Cisneros-Zevallos, L., & Heredia, J. B. (2016).
Protective role of terpenes and polyphenols from three species of Oregano (Lippia
graveolens, Lippia palmeri and Hedeoma patens) on the suppression of
lipopolysaccharide-induced inflammation in RAW 264.7 macrophage cells.
Journal of Ethnopharmacology, 187, 302-312.
http://dx.doi.org/10.1016/j.jep.2016.04.051
Lotholary, O., Desnos-Ollivier, M., Sitbon, K., Fontanet, A., Bretagne, S., & Dromer, F.
(2011). Recent exposure to caspofungin or fluconazole influences the
epidemiology of candidemia: A prospective multicenter study involving 2,441
patients. Antimicrobial Agents and Chemotherapy, 55(2), 532–538.

135
http://dx.doi.org/10.1128/AAC.01128-10
MacLean, R. C. (2010). Predicting epistasis: An experimental test of metabolic control
theory with bacterial transcription and translation. Journal of Evolutionary
Biology, 23(3), 488-493. http://dx.doi.org/10.1111/j.1420-9101.2009.01888.x
Marin, S., Sanchis, V., & Ramos, A. J. (2011). Plant products in the control of
mycotoxins and mycotoxigenic fungi on food commodities. In N. K. Dubey (Ed.),
Natural products in plant pest management (pp. 21-41). Retrieved from
http://agro.irimo.ir/parameters/weather/modules/cdk/upload/content/article/865/N
atural%20Products%20in%20Plant%20Pest%20Management.pdf#page=34
Mehra, T., Koberle, M., Braunsdorf, C., Mailander-Sanchez, D., Borelli, C., & Schaller,
M. (2013). Alternative approaches to antifungal therapies. Experimental
Dermatology, 21(10), 778-782. http://dx.doi.org/ 10.1111/exd.12004
Molyneux, R. J., Mahoney, N., Kim, J. H., & Campbell, B. C. (2007). Mycotoxins in
edible tree nuts. International Journal of Food Microbiology, 119, 72-78.
http://dx.doi.org/10.1016/j.ijfoodmicro.2007.07.028
Mukherjee, P. K., Chandra, J., Kuhn, D. M., & Ghannoum, M. A. (2003). Mechanism of
fluconazole resistance in Candida albicans biofilms: Phase-specific role of efflux
pumps and membrane sterols. Infection and Immunity, 71(8), 4333-4340.
http://dx.doi.org/10.1128/IAI.71.8.4333–4340.2003
Nasir, M., Tafess, K., & Abate, D. (2015). Antimicrobial potential of the Ethiopian
Thymus schimperi essential oil in comparison with others against certain fungal
and bacterial species. BioMed Central: Complementary and Alternative Medicine,

136
15(260). http://dx.doi.org/10.1186/s12906-015-0784-3
Omran, S. M., & Esmailzadeh, S. (2009). Comparison of anti-Candida activity of thyme,
pennyroyal, and lemon essential oils versus antifungal drugs against Candida
species. Jundishapur Journal of Microbiology, 2(2), 53-60. Retrieved from
http://en.journals.sid.ir/ViewPaper.aspx?ID=174865
Orr, P. (2005). Otitis media and the epidemiologic triangle. International Journal of
Circumpolar Health, 64(1), 2-3. Retrieved from
http://www.circumpolarhealthjournal.net/index.php/ijch/article/view/17947
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., OstroskyZeichner, L., ... Sobel, J. D. (2016). Clinical practice guideline for the
management of candidiasis: 2016 update by the Infectious Diseases Society of
America. Clinical Infectious Diseases, 62(4), e1-e50.
http://dx.doi.org/10.1093/cid/civ933
Pellegrino, B., Onder, S., & Schmidt, R. J. (n.d.). Immunosuppression. Retrieved April 5,
2015, from http://emedicine.medscape.com/article/432316-overview#showall
Pozatti, P., Scheid, L. A., Spader, T. B., Atayde, M. L., Santurio, J. M., & Alves, S. H.
(2008). In vitro activity of essential oils extracted from plants used as spices
against fluconazole-resistant and fluconazole-susceptible Candida spp. Canadian
Journal Of Microbiology, 54(11), 950-956. http://dx.doi.org/10.1139/w08-097
Rajendran, R., Sherry, L., Nile, C. J., Sherriff, A., Johnson, E. M., Hanson, M. F., ...
Ramage, G. (2016). Biofilm formation is a risk factor for mortality in patients
with Candida albicans bloodstream infection—Scotland, 2012 –2013. Clinical

137
Microbiology and Infection, 22(1), 87-93. http://dx.doi.org/
10.1016/j.cmi.2015.09.018
Rajkowska, K., Kunicka-Stycynska, A., Maroszynska, M., & Dabrowska, M. (2014). The
effect of thyme and tea tree oils on morphology and metabolism of Candida
albicans. The Journal of the Polish Biochemical Society and of the Committee of
Biochemistry and Biophysics Polish Academy of Sciences, 61(2), 305-310.
Retrieved from http://www.actabp.pl/pdf/2_2014/305.pdf
Ramage, G., Mulligan, S., Lappin, D. F., Sherry, L., Sweeney, P., Williams, C., ...
Culshaw, S. (2012). Antifungal, cytotoxic and immunomodulatory properties of
tea tree oil and its derivative components: potential role in management of oral
candidiosis in cancer patients. Frontiers in Microbiology, 3(220).
http://dx.doi.org/10.3389/fmicb.2012.00220
Rath, C. C., & Mohapatra, S. (2015). Susceptibility characterisation of Candida spp. to
four essential oils. Indian Journal of Medical Microbiology, 33(Supplement 1),
S93-96. http://dx.doi.org/10.4103/0255-0857.150903
Research Randomizer. (n.d.). Retreived from randomizer.org
Rodrigues, C. E., Rodrigues, M. E., Silva, S., & Henriques, M. (2017). Candida glabrata
biofilms: How far have we come?. Journal of fungi, 3(11).
http://dx.doi.org/10.3390/jof3010011
Saad, A., Fadli, M., Bouazz, M., Benharref, A., Mezrioui, N. E., & Hassani, L. (2010).
Anticandidal activity of the essential oils of Thymus maroccanus and Thymus
broussonetii and their synergism with amphotericin B and fluconazole.

138
Phytomedicine, 17, 1057-1060. http://dx.doi.org/10.1016/j.phymed.2010.03.020
Sajjad Ahmad Khan, M., & Ahmad, I. (2012). Biofilm inhibition by Cymbopogon
citratus and Syzygiumaromaticum essential oils in the strains of Candida albicans.
Journal of Ethnopharmacology, 140(2), 416-423.
http://dx.doi.org/10.1016/j.jep.2012.01.045
Sajjad Ahmad Khan, M., Malik, A., & Ahmad, I. (2012). Anti-candidal activity of
essential oils alone and in combination with amphotericin B or fluconazole
against multi-drug resistant isolates of Candida albicans. Medical Mycology,
50(1), 33-42. http://dx.doi.org/10.3109/13693786.2011.582890
Sanguinetti, M., Posteraro, B., & Lass-Florl, C. (2015). Antifungal drug resistance among
Candida species: Mechanisms and clinical impact. Mycoses, 58(Suppl. 2), 2-13.
http://dx.doi.org/10.1111/myc.12330
Shah, G., Shri, R., Panchal, V., Sharma, N., Singh, B., & Mann, A. S. (2011). Scientific
basis for the therapeutic use of Cymbopogon citratus, stapf (lemon grass). Journal
of Advanced Pharmaceutical Technology & Research, 2(1), 3-8.
http://dx.doi.org/10.4103/2231-4040.79796
Shigemura, K., Osawa, K., Jikimoto, T., Yoshida, H., Hayama, B., Ohji, G., ... Arakawa,
S. (2014). Comparison of the clinical risk factors between Candida albicans and
Candida non-albicans species for bloodstream infection. The Journal of
Antibiotics, 67(4), 311-314. http://dx.doi.org/10.1038/ja.2013.141
Sidhu, O. P., Chandra, H., & Behl, H. M. (2009). Occurrence of aflatoxins in mahua
(Madhuca indicaGmel.) seeds: Synergistic effect of plant extracts on inhibition of

139
Aspergillus flavus growth and aflatoxin production. Food and Chemical
Toxicology, 47, 774-777. http://dx.doi.org/10.1016/j.fct.2009.01.001
Silva, P. M., Goncalves, S., & Santos, N. C. (2014). Defensins: Antifungal lessons from
eukaryotes. Frontiers in Microbiology.
http://dx.doi.org/10.3389/fmicb.2014.00097
Sinha, S., Jothiramajayam, M., Ghosh, M., & Mukherjee, A. (2014). Evaluation of
toxicity of essential oils palmarosa, citronella, lemongrass and vetiver in human
lymphocytes. Food and Chemical Toxicology, 68, 71-77.
http://dx.doi.org/10.1016/j.fct.2014.02.036
Soumpasis, I., Knapp, L., & Pitt, T. (2015). A proof-of-concept model for the
identification of the key events in the infection process with specific reference to
Pseudomonas aeruginosa in corneal infections. Infection Ecology &
Epidemiology, 5. http://dx.doi.org/10.3402/iee.v5.28750
Teixeira, B., Marques, A., Ramos, C., Serrano, C., Matos, O., Neng, N. R., ... Nunes, M.
L. (2013). Chemical composition and bioactivity of different oregano (Origanum
vulgare) extracts and essential oil. Journal of the Science of Food and
Agriculture, 93(11), 2707–2714. http://dx.doi.org/10.1002/jsfa.6089
Tepe, B., Daferera, D., Sokmen, M., Polissiou, M., & Sokmen, A. (2004). In vitro
antimicrobial and antioxidant activities of the essential oils and various extracts of
Thymus eigii. Journal of Agricultural and Food Chemistry, 52, 1132-1137.
http://dx.doi.org/10.1021/jf035094l
Traore, O., Springthorpe, V. S., & Sattar, S. A. (2002). A quantitative study of the

140
survival of two species of Candida on porous and non-porous environmental
surfaces and hands. Journal of Applied Microbiology, 92(3), 549-555.
http://dx.doi.org/10.1046/j.1365-2672.2002.01560.x
Turgis, M., Han, J., Caillet, S., & Lacroix, M. (2009). Antimicrobial activity of mustard
essential oil against Escherichia coli O157:H7 and Salmonella typhi. Food
Control, 20(12), 1073-1079. http://dx.doi.org/10.1016/j.foodcont.2009.02.001
Tyagi, A. K., & Malik, A. (2010). Liquid and vapour-phase antifungal activities of
selected essential oils against Candida albicans: Microscopic observations and
chemical characterization of Cymbopogon citratus. BioMed Central:
Complementary and Alternative Medicine, 10(65).
http://dx.doi.org/10.1186/1472-6882-10-65
Ueno, K., Matsumoto, Y., Uno, J., Sasamoto, K., Sekimizu, K., Kinjo, Y., & Chibaba, H.
(2011). Intestinal resident yeast Candida glabrata requires Cyb2p-mediated lactate
assimilation to adapt in mouse intestine. PLoS ONE, 6(9).
http://dx.doi.org/10.1371/journal.pone.0024759
United States Census Bureau website. (n.d.). http://www.census.gov/
University of Colorado Health. (n.d.). Institutional review board. Retrieved May 16,
2015, from https://www.uchealth.org/northerncolorado/Pages/AboutUs/Institutional-Review-Board.aspx
Varadarajan, S., Narasimhan, M., Malaisamy, M., & Duraipandian, C. (2015). Invitro
anti-mycotic activity of hydro alcoholic extracts of some Indian medicinal plants
against Fluconazole resistant Candida albicans. Journal of Clinical and

141
Diagnostic Research, 9(8), ZC06-ZC10.
http://dx.doi.org/10.7860/JCDR/2015/14178.6273
Vylkova, S., & Lorenz, M. C. (2014). Modulation of phagosomal pH by Candida albicans
promotes hyphal morphogenesis and requires Stp2p, A regulator of amino acid
transport. PLoS Pathogens, 10(3). http://dx.doi.org/ 10.1371/journal.ppat.1003995
Wanke, B., Dos Santos Lazera, M., & Nucci, M. (2000). Fungal infections in the
immunocompromised host. Mem Inst Oswaldo Cruz, Rio de Janeiro, 95(Suppl.
1), 153-158. Retrieved from http://www.scielo.br/pdf/mioc/v95s1/v95s1a25.pdf
Watamoto, T., Samaranayake, L. P., Jayatilake, J., Egusa, H., Yatani, H., & Seneviratne,
C. J. (2009). Effect of filamentation and model of growth on antifungal
susceptibility of Candida albicans. International Journal of Antimicrobial Agents,
34, 333-339. http://dx.doi.org/10.1016/j.ijantimicag.2009.03.008
Williams, D. W., Jordan, R. P., Wei, X., Alves, C. T., Wise, M. P., Wilson, M. J., &
Lewis, M. A. (2013). Interactions of Candida albicans with host epithelial
surfaces. Journal of Oral Microbiology, 5(22434).
http://dx.doi.org/10.3402/jom.v5i0.22434
Woolfrey, B. F., Lally, R. T., & Tait, K. R. (1986). Influence of technical factor
variations on Serum Inhibition and Bactericidal Titers. Journal of Clinical
Microbiology, 23(6), 997-1000. Retrieved from
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC268779/pdf/jcm00107-0019.pdf
Xi Yap, P. S., Lim, S. H., Hu, C. P., & Yiap, B. C. (2013). Combination of essential oils
and antibiotics reduce antibiotic resistance in plasmid-conferred multidrug

142
resistant bacteria. Phytomedicine, 20, 710-713.
http://dx.doi.org/10.1016/j.phymed.2013.02.013
Yang, Z., Wu, L., Liu, X., Zhou, M., Li, J., Wu, J., ... Lortholary, O. (2014).
Epidemiology, species distribution and outcome of nosocomial Candida spp.
bloodstream infection in Shanghai. BioMed Central Infectious Diseases, 14(241).
http://dx.doi.org/10.1186/1471-2334-14-241
Zaoutis, T. E., Argon, J., Chu, J., Berlin, J. A., Walsh, T. J., & Feudtner, C. (2005). The
epidemiology and attributable outcomes of candidemia in adults and children
hospitalized in the United States: A propensity analysis. Clinical Infectious
Diseases, 41(9), 1232-1239. http://dx.doi.org/10.1086/496922

